J. Verhoef

发表

New treatment modalities for serious Gram-negative bacterial infections.

J. Verhoef, 1993, International journal of antimicrobial agents.

Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon-α, and Interferon-γ in the Serum of Patients with Septic Shock

J. Schellekens, T. Calandra, G. Grau, 1990 .

Surveillance of nosocomial infections in geriatric patients.

J. Verhoef, C. Vandenbroucke-Grauls, D. Beaujean, 1997, The Journal of hospital infection.

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus.

J. Verhoef, F. Schmitz, A. Fluit, 1998, The Journal of antimicrobial chemotherapy.

The magnetic immuno polymerase chain reaction assay for direct detection of salmonellae in fecal samples

J. Verhoef, R. Torensma, A. Fluit, 1992, Journal of clinical microbiology.

Relationship of bacterial growth phase to killing of Listeria monocytogenes by oxidative agents generated by neutrophils and enzyme systems

J. Verhoef, C. Vandenbroucke-Grauls, R. Bortolussi, 1987, Infection and immunity.

Phylogenetic diversity of Klebsiella pneumoniae and Klebsiella oxytoca clinical isolates revealed by randomly amplified polymorphic DNA, gyrA and parC genes sequencing and automated ribotyping.

S. Brisse, J. Verhoef, 2001, International journal of systematic and evolutionary microbiology.

Carriage of gram-negative bacilli in young Brazilian children with community-acquired pneumonia.

J. Verhoef, A. Fleer, L. Rey, 2001, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Development of a rapid identification method for Klebsiella pneumoniae phylogenetic groups and analysis of 420 clinical isolates.

S. Brisse, J. Verhoef, T. V. van Himbergen, 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Multilocus Sequence Typing of Klebsiella pneumoniae Nosocomial Isolates

Sylvain Brisse, Patrick A. D. Grimont, S. Brisse, 2005, Journal of Clinical Microbiology.

Evidence of extensive interspecies transfer of integron-mediated antimicrobial resistance genes among multidrug-resistant Enterobacteriaceae in a clinical setting.

J. Verhoef, H. Blok, A. Paauw, 2002, The Journal of infectious diseases.

Empiric antimicrobial therapy

J. Verhoef, 1991 .

Evaluation of the Magnetic Immuno PCR assay for rapid detection ofSalmonella

J. Verhoef, R. Torensma, A. Fluit, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Monoclonal antibodies that identify gram-negative bacteria using the magnetic immunoluminescence assay

J. Verhoef, R. Torensma, A. Fluit, 1992 .

Antimicrobial resistance among urinary tract infection (UTI) isolates in Europe: results from the SENTRY Antimicrobial Surveillance Program 1997

J. Verhoef, A. Fluit, Mark E. Jones, 2000, Antonie van Leeuwenhoek.

Acquisition and Cross-Transmission of Staphylococcus aureus in European Intensive Care Units

L. Argaud, A. Resende, J. Verhoef, 2009, Infection Control & Hospital Epidemiology.

Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998.

J. Verhoef, F. Schmitz, A. Fluit, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Typing of methicillin-resistant Staphylococcus aureus isolates from Düsseldorf by six genotypic methods.

K. Köhrer, M. Steiert, J. Verhoef, 1998, Journal of medical microbiology.

Synthetic 6B Di-, Tri-, and Tetrasaccharide-Protein Conjugates Contain Pneumococcal Type 6A and 6B Common and 6B- Specific Epitopes That Elicit Protective Antibodies in Mice

J. Vliegenthart, J. Verhoef, J. Kamerling, 2001, Infection and Immunity.

Comparison of three days' therapy with cefcanel or amoxicillin for the treatment of acute uncomplicated urinary tract infection.

L. Nicolle, J. Verhoef, A. Hoepelman, 1993, Scandinavian journal of infectious diseases.

Inactivation of recombinant human tumor necrosis factor-alpha by proteolytic enzymes released from stimulated human neutrophils.

J. Verhoef, J. V. van Strijp, J. Strijp, 1991, Journal of immunology.

Immune Response in Human Pathology: Infections Caused by Bacteria, Viruses, Fungi, and Parasites

J. Verhoef, H. Snippe, K. V. van Kessel, 2019, Nijkamp and Parnham's Principles of Immunopharmacology.

Saturable CD14-dependent binding of fluorescein-labeled lipopolysaccharide to human monocytes

A. Troelstra, J. Verhoef, A. Weersink, 1997, Infection and immunity.

Lipopolysaccharide-Induced Tumor Necrosis Factor Alpha Production by Human Monocytes Involves the Raf-1/MEK1-MEK2/ERK1-ERK2 Pathway

J. Verhoef, T. van der Bruggen, S. Nijenhuis, 1999, Infection and Immunity.

Quantitative assay for testing susceptibility of HIV isolates to zidovudine and sCD4 (178)-PE40

H. Balfour, J. Verhoef, P. Peterson, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Two rapid complementary methods to detect progressive zidovudine resistance mutations in mononuclear cells of HIV-infected patients.

M. Visser, J. Verhoef, J. Borleffs, 1996, International journal of antimicrobial agents.

Bacterial resistance: A sensitive issue

J. Verhoef, A. Fluit, W. Jansen, 2006, Drug Resistance Updates.

Molecular Surveillance of European Quinolone-Resistant Clinical Isolates of Pseudomonas aeruginosa andAcinetobacter spp. Using Automated Ribotyping

S. Brisse, J. Verhoef, A. Fluit, 2000, Journal of Clinical Microbiology.

Amplification methods in diagnostic microbiology

J. Verhoef, M. Altwegg, 1995 .

Interactions of phagocytic and bacterial cells in patients with bacteremia caused by gram-negative rods.

H. Verbrugh, J. Verhoef, P. Peterson, 1980, The Journal of infectious diseases.

Toxins A and B of Clostridium difficile.

J. Verhoef, M. Wolfhagen, R. Torensma, 1994, FEMS microbiology reviews.

Control of epidemic methicillin-resistantStaphylococcus aureus in a Dutch University Hospital

J. Verhoef, C. Vandenbroucke-Grauls, B. Klingeren, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains

J. Verhoef, H. Idel, H. Heinz, 1997, European Journal of Epidemiology.

Methicillin resistant Staphylococcus aureus strains in the greater Düsseldorf area

J. Verhoef, H. Idel, H. Heinz, 1997, European Journal of Epidemiology.

Phenotypic characterization of epidemic versus sporadic strains of methicillin-resistant Staphylococcus aureus

J. Verhoef, W. V. van Wamel, C. Vandenbroucke-Grauls, 1995, Journal of clinical microbiology.

Prognostic values of tumor necrosis factor/cachectin, interleukin-1, interferon-alpha, and interferon-gamma in the serum of patients with septic shock. Swiss-Dutch J5 Immunoglobulin Study Group.

J. Schellekens, T. Calandra, G. Grau, 1990, The Journal of infectious diseases.

Direct evidence for antibody bipolar bridging on herpes simplex virus-infected cells.

J. Verhoef, J. V. van Strijp, L. A. de Graaf-Miltenburg, 1992, Immunology.

Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals.

K. Köhrer, J. Verhoef, A. Fluit, 2000, The Journal of antimicrobial chemotherapy.

The millennium bugs--the need for and development of new antibacterials.

J. Verhoef, R. Bax, N. Mullan, 2000, International journal of antimicrobial agents.

Prevention of infections in the neutropenic patient.

J. Verhoef, J. Verhoef, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

An outbreak of Serratia marcescens traced to a contaminated bronchoscope.

M. Visser, J. Verhoef, C. Vandenbroucke-Grauls, 1993, The Journal of hospital infection.

Antibiotic resistance: the pandemic.

J. Verhoef, 2003, Advances in experimental medicine and biology.

Surveillance of resistance against antimicrobial agents: a European perspective.

J. Verhoef, R. Gupta, 1999, The Journal of hospital infection.

Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes

J. Verhoef, C. Vandenbroucke-Grauls, J. Marx, 1990, Infection and immunity.

In Vitro Activity of AR-709 against Streptococcus pneumoniae

J. Verhoef, D. Milatovic, W. Jansen, 2008, Antimicrobial Agents and Chemotherapy.

Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells

J. Verhoef, A. Verheul, H. Snippe, 1997, Infection and immunity.

Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.

J. Turnidge, J. Verhoef, M. Pfaller, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antimicrobial susceptibility of imipenem-resistant Pseudomonas aeruginosa.

J. Verhoef, P. Higgins, F. Schmitz, 2002, The Journal of antimicrobial chemotherapy.

Genogeography and Immune Epitope Characteristics of Hepatitis B Virus Genotype C Reveals Two Distinct Types: Asian and Papua-Pacific

Turyadi, J. Verhoef, S. Marzuki, 2015, PloS one.

pathogenesis, and vaccines. Streptococcus pneumoniae: virulence factors,

J. Verhoef, A. Verheul, H. Snippe, 2013 .

Synthetic peptides representing T-cell epitopes act as carriers in pneumococcal polysaccharide conjugate vaccines

W. van Eden, J. Verhoef, R. van der Zee, 1995, Infection and immunity.

Comparison of a Classical Phagocytosis Assay and a Flow Cytometry Assay for Assessment of the Phagocytic Capacity of Sera from Adults Vaccinated with a Pneumococcal Conjugate Vaccine

M. Nahm, J. Verhoef, H. Käyhty, 2001, Clinical Diagnostic Laboratory Immunology.

International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).

J. Verhoef, M. Pfaller, G. Doern, 1999, Diagnostic microbiology and infectious disease.

Macrophages, cytokines, and HIV.

J. Verhoef, P. Peterson, M. Bornemann, 1997, The Journal of laboratory and clinical medicine.

Effect of iron on serotypes and haemagglutination patterns ofEscherichia coli in bottle-fed infants

J. Verhoef, P. Guiñee, J. Marcelis, 1985, European Journal of Clinical Microbiology.

Molecular identification of bacteria by fluorescence-based PCR-single-strand conformation polymorphism analysis of the 16S rRNA gene

J. Verhoef, A. Fluit, M. Widjojoatmodjo, 1995, Journal of clinical microbiology.

Toon van Pathway Complement Activation Lipopolysaccharide-Mediated Classical Gram-Negative Bacteria Prevents Serum Amyloid P Component Bound to

J. Verhoef, De, Haas, 2000 .

Analysis of lipopolysaccharide (LPS)-binding characteristics of serum components using gel filtration of FITC-labeled LPS.

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 2000, Journal of immunological methods.

Lipopolysaccharide (LPS)-Binding Synthetic Peptides Derived from Serum Amyloid P Component Neutralize LPS

J. Verhoef, R. van der Zee, J. V. van Strijp, 1999, Infection and Immunity.

A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood.

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 1998, Journal of immunology.

The role of Staphylococcus aureus cell-wall peptidoglycan, teichoic acid and protein A in the processes of complement activation and opsonization.

H. Verbrugh, J. Verhoef, W. V. van Dijk, 1979, Immunology.

Control of Nosocomial Multiresistant Enterobacteriaceae Using a Temporary Restrictive Antibiotic Agent Policy

J. Verhoef, H. Blok, A. Weersink, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

Detection of Listeria monocytogenes in cheese with the magnetic immuno-polymerase chain reaction assay

J. Verhoef, P. Klapwijk, R. Torensma, 1993, Applied and environmental microbiology.

The Antimicrobial agents annual

J. Verhoef, P. Peterson, 1986 .

Molecular surveillance of macrolide, tetracycline and quinolone resistance mechanisms in 1191 clinical European Streptococcus pneumoniae isolates.

J. Verhoef, F. Schmitz, A. Fluit, 2001, International journal of antimicrobial agents.

Characterization of Dutch Staphylococcus aureus from bovine mastitis using a Multiple Locus Variable Number Tandem Repeat Analysis.

J. Verhoef, D. Mevius, A. Fluit, 2009, Veterinary microbiology.

Novel Multiple-Locus Variable-Number Tandem-Repeat Analysis Method for Rapid Molecular Typing of Human Staphylococcus aureus

J. Verhoef, R. Willems, A. Fluit, 2008, Journal of Clinical Microbiology.

Genetic Diversity Among Strains of Moraxella catarrhalis Cultured from the Nasopharynx of Young and Healthy Brazilian, Angolan and Dutch Children

A. van Belkum, J. Verhoef, L. Rey, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

From the Immunocompromised Host Society. The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient. Report of a consensus panel.

J. Karp, J. Verhoef, L. Young, 1990, The Journal of infectious diseases.

J Verhoef 16 S rRNA gene . conformation polymorphism analysis of the fluorescence-based PCR-single-strand Molecular identification of bacteria

J. Verhoef, A. Fluit, M. Widjojoatmodjo, 1995 .

Rapid identification of bacteria by PCR-single-strand conformation polymorphism

J. Verhoef, A. Fluit, M. Widjojoatmodjo, 1994, Journal of clinical microbiology.

Structural Alterations in the Translational Attenuator of Constitutively Expressed erm(A) Genes inStaphylococcus aureus

K. Köhrer, J. Verhoef, F. Schmitz, 2001, Antimicrobial Agents and Chemotherapy.

Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. Sentry Participants Group.

J. Verhoef, F. Schmitz, A. Fluit, 1999, The Journal of antimicrobial chemotherapy.

Prevention of colonization and infection in critically ill patients: a prospective randomized study.

J. Verhoef, J. H. Rommes, A. J. Kerver, 1988, Critical care medicine.

Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy.

A. Girbes, P. Speelman, M. Bonten, 2000, The Journal of antimicrobial chemotherapy.

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.

M. Rozenberg-Arska, J. Verhoef, A. Dekker, 1985, The Journal of infectious diseases.

Glycopeptide Antibacterials and the Treatment of Biofilm-Related Infections

J. Verhoef, J. Pace, R. Verna, 2005 .

Modulation of adherence of coagulase-negative staphylococci to teflon catheters in vitro

J. Verhoef, A. Fleer, N. Westerdaal, 1986, European Journal of Clinical Microbiology.

Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayers.

H. Verbrugh, J. Verhoef, I. Haagen, 1990, The Journal of infectious diseases.

Pharmacokinetics of a single dose of ofloxacin in healthy elderly subjects using noncompartmental and compartmental models

J. Verhoef, C. Rademaker, J. Glerum, 1989, Pharmaceutisch Weekblad.

EndemicAcinetobacter anitratus in a surgical intensive care unit: Mechanical ventilators as reservoir

J. Verhoef, C. Vandenbroucke-Grauls, J. H. Rommes, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Surveillance for Hospital-Acquired Infections on Surgical Wards in a Dutch University Hospital

A. Troelstra, J. Verhoef, C. Vandenbroucke-Grauls, 2003, Infection Control & Hospital Epidemiology.

Characterization of anti-core glycolipid monoclonal antibodies with chemically defined lipopolysaccharides

J. Schellekens, J. Verhoef, J. de Jongh-Leuvenink, 1990, Infection and immunity.

Comparison of the autoSCAN-W/A and Vitek automicrobic systems for identification and susceptibility testing of bacteria

M. Rozenberg-Arska, M. Visser, J. Verhoef, 1992, European Journal of Clinical Microbiology and Infectious Diseases.

Relative risk of physicians and nurses to transmit pathogens in a medical intensive care unit.

R. Weinstein, C. Franklin, M. Bonten, 2003, Archives of internal medicine.

Dynamics in Prophage Content of Invasive and Noninvasive M1 and M28 Streptococcus pyogenes Isolates in The Netherlands from 1959 to 1996

L. Schouls, F. Schuren, M. Caspers, 2007, Infection and Immunity.

Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992–1996

L. Schouls, J. Verhoef, W. Pelt, 2004, European Journal of Clinical Microbiology and Infectious Diseases.

Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type Distribution and Corresponding Patterns of Virulence Determinants

J. Schellekens, L. Schouls, J. Verhoef, 2003, Journal of Clinical Microbiology.

Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.

J. Schellekens, L. Schouls, J. Musser, 2000, The Journal of infectious diseases.

Invasive and Noninvasive Group A Streptococcal Isolates with Different speA Alleles in The Netherlands: Genetic Relatedness and Production of Pyrogenic Exotoxins A and B

L. Schouls, J. Verhoef, A. Fluit, 1999, Journal of Clinical Microbiology.

Population Staphylococcus aureus Gene Is Widely Disseminated in mecA

S. Brisse, J. Verhoef, A. Fluit, 2002 .

Nasopharyngeal S. pneumoniae isolates from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility

J. Verhoef, L. Rey, B. Wolf, 2002 .

S. pneumoniae isolados da nasofaringe de crianças sadias e com pneumonia: taxa de colonização e suscetibilidade aos antimicrobianos Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility

J. Verhoef, L. Rey, B. Wolf, 2002 .

[Nasopharyngeal isolates of S. pneumoniae from healthy carriers and children with pneumonia: colonization rates and antimicrobial susceptibility].

J. Verhoef, L. Rey, B. Wolf, 2002, Jornal de Pediatria.

Antimicrobial susceptibility and serotypes of nasopharyngeal Streptococcus pneumoniae in children with pneumonia and in children attending day-care centres in Fortaleza, Brazil.

J. Verhoef, L. Rey, B. Wolf, 2002, International journal of antimicrobial agents.

Discrimination of epidemic and nonepidemic methicillin-resistant Staphylococcus aureus strains on the basis of protein A gene polymorphism

F. Mooi, L. Schouls, J. Verhoef, 1994, Journal of clinical microbiology.

Digoxigenin labelled DNA probes for rapid detection of enterotoxigenic, enteropathogenic and Vero cytotoxin producing Escherichia coli in faecal samples

J. Verhoef, M. Wolfhagen, C. Rademaker, 1992 .

The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals.

J. Verhoef, A. Fluit, B. Hofmann, 1998, The Journal of antimicrobial chemotherapy.

Epidemiology and Susceptibility of 3,051Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European SENTRY Study

J. Verhoef, A. Fluit, F. Schmitz, 2001, Journal of Clinical Microbiology.

Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.

A. Donker, H. Verbrugh, J. Verhoef, 1992, Kidney international.

Funct iona l defects in phagocyt ic cells

J. Verhoef, A. Struyvenberg, S. V. Asbeck, 2004 .

Modulation of lipopolysaccharide binding to human granulocytes.

J. Verhoef, A. Weersink, K. V. van Kessel, 1994, Immunology.

Cross-protection by anti-core glycolipid antibodies: evidence from animal experiments.

J. Verhoef, A. Hoepelman, W. Hustinx, 1997, The Journal of antimicrobial chemotherapy.

Bacterial and viral removal efficiency, heat and moisture exchange properties of four filtration devices.

J. Verhoef, C. Lavooij, C. M. Vanderbroucke-Grauls, 1995, The Journal of hospital infection.

Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).

J. Verhoef, R. Jones, A. Gales, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Complement activating and opsonic capacity of monoclonal antibodies raised againstEscherichia coli O111 and its rough mutant J5

J. Verhoef, E. Brouwer, J. Marcelis, 1986, European Journal of Clinical Microbiology.

Origin? -Lactamase: a Lipoprotein of Gram-Positive β Moraxella (Branhamella)catarrhalis BRO

F. Mooi, J. Verhoef, H. Bootsma, 2013 .

Genesis of BRO β‐lactamase‐producing Moraxella catarrhalis: evidence for transformation‐mediated horizontal transfer

F. Mooi, P. Vauterin, J. Verhoef, 2000, Molecular microbiology.

Moraxella (Branhamella)catarrhalis BRO β-Lactamase: a Lipoprotein of Gram-Positive Origin?

J. Verhoef, H. Bootsma, G. Posthuma, 1999, Journal of bacteriology.

Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis

F. Mooi, J. Verhoef, A. Fleer, 1996, Antimicrobial agents and chemotherapy.

Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.

J. Verhoef, C. Verduin, H. van Dijk, 1994, The Journal of infectious diseases.

Rapid detection of salmonellae in poultry with the magnetic immuno-polymerase chain reaction assay

J. Verhoef, R. Torensma, A. Fluit, 1993, Applied and environmental microbiology.

Monoclonal antibodies that detect live salmonellae

J. Verhoef, R. Torensma, A. Fluit, 1992, Applied and environmental microbiology.

Differences in complement activation between complement-resistant and complement-sensitive Moraxella (Branhamella) catarrhalis strains occur at the level of membrane attack complex formation

J. Verhoef, T. Mollnes, C. Verduin, 1994, Infection and immunity.

Detection of Salmonella species in fecal samples by immunomagnetic separation and PCR.

J. Verhoef, A. Fluit, M. Widjojoatmodjo, 1995, Journal of clinical microbiology.

Role for oxygen radicals in self‐sustained HIV‐1 replication in monocyte‐derived macrophages: enhanced HIV‐1 replication by N‐acetyl‐L‐cysteine

M. Visser, J. Verhoef, B. Asbeck, 1994, Journal of leukocyte biology.

Surveillance uncovers the smoking gun for resistance emergence.

J. Verhoef, A. Fluit, 2006, Biochemical pharmacology.

Bifidobacterium, Bacteroides, and Clostridium spp. in fecal samples from breast-fed and bottle-fed infants with and without iron supplement

J. Verhoef, J. Marcelis, E. Mevissen-Verhage, 1987, Journal of clinical microbiology.

Mechanism of protection of alveolar type II cells against paraquat-induced cytotoxicity by deferoxamine.

J. Verhoef, J. van Oirschot, B. S. van Asbeck, 1990, Biochemical pharmacology.

Spare CD14 molecules on human monocytes enhance the sensitivity for low LPS concentrations.

J. Verhoef, J. V. van Strijp, P. Antal-Szalmás, 2004, Immunology letters.

Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes

J. Verhoef, J. Marx, I. Hoepelman, 1989, British journal of haematology.

A view to a kill: cytotoxic mechanisms of human polymorphonuclear leukocytes compared with monocytes and natural killer cells.

J. Verhoef, K. V. van Kessel, 1990, Pathobiology : journal of immunopathology, molecular and cellular biology.

Antimicrobial Functions of Neutrophils

M. Rozenberg-Arska, J. Verhoef, I. Hoepelman, 1989 .

The role of high density lipoprotein in sepsis.

A. V. van Beek, J. Verhoef, G. Dallinga-Thie, 2001 .

Once-daily aminoglycoside administration: New strategies for an old drug

J. Kovarik, J. Verhoef, I. Hoepelman, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes

J. Verhoef, R. Norrby, H. van Dijk, 1996, Infection and immunity.

[Spread and control of a methicillin-resistant Staphylococcus aureus in an academic hospital].

J. Verhoef, C. Vandenbroucke-Grauls, J. H. Rommes, 1990, Nederlands tijdschrift voor geneeskunde.

Anti-polysaccharide immunoglobulin isotype levels and opsonic activity of antisera: relationships with protection against Streptococcus pneumoniae infection in mice.

R. Feldman, J. Verhoef, A. Verheul, 1995, The Journal of infectious diseases.

Use of Highly Encapsulated Streptococcus pneumoniae Strains in a Flow-Cytometric Assay for Assessment of the Phagocytic Capacity of Serotype-Specific Antibodies

J. Verhoef, M. Zelle, D. Madore, 1998, Clinical Diagnostic Laboratory Immunology.

Epitope specificity of rabbit immunoglobulin G (IgG) elicited by pneumococcal type 23F synthetic oligosaccharide- and native polysaccharide-protein conjugate vaccines: comparison with human anti-polysaccharide 23F IgG

R. Feldman, J. Verhoef, J. Kamerling, 1994, Infection and immunity.

Pneumococcal virulence factors and host immune responses to them

D. Musher, J. Verhoef, D. Watson, 1995, European Journal of Clinical Microbiology and Infectious Diseases.

Dual effects of soluble CD14 on LPS priming of neutrophils

A. Troelstra, B. Giepmans, J. Verhoef, 1997, Journal of leukocyte biology.

Diverging pathways for lipopolysaccharide and CD14 in human monocytes.

J. Verhoef, R. Broekhuizen, J. V. van Strijp, 2000, Cytometry.

Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium.

A. Troelstra, M. Bonten, M. Bonten, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Value of Terminal Subculture of Automated Blood Cultures in Patients with Candidaemia

J. Verhoef, A. Fluit, M. L. Leverstein-van Hall, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Enterobacter cloacae Outbreak and Emergence of Quinolone Resistance Gene in Dutch Hospital

J. Verhoef, A. Paauw, A. Fluit, 2006, Emerging infectious diseases.

Multidrug resistance among Enterobacteriaceae is strongly associated with the presence of integrons and is independent of species or isolate origin.

J. Verhoef, A. Paauw, A. Fluit, 2003, The Journal of infectious diseases.

Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.

W. Voorhout, J. Verhoef, J. V. van Strijp, 1995, The Journal of infectious diseases.

Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.

L. Schouls, J. Verhoef, H. van Dijk, 2001, International journal of antimicrobial agents.

Surveillance of antibiotic resistance.

J. Verhoef, 1999, Current opinion in infectious diseases.

Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans

H. Verbrugh, J. Verhoef, L. Martínez-Martínez, 1993, Infection and immunity.

Novel Mobile Variants of Staphylococcal Cassette Chromosome mec in Staphylococcus aureus

J. Verhoef, W. V. van Wamel, A. Fluit, 2006, Antimicrobial Agents and Chemotherapy.

Priorities for antibiotic resistance surveillance in Europe.

F. Aarestrup, J. Verhoef, A. Fluit, 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Automated Ribotyping of Vancomycin-Resistant Enterococcus faecium Isolates

S. Brisse, J. Verhoef, R. Willems, 2002, Journal of Clinical Microbiology.

Outbreak of a susceptible strain of Acinetobacter species 13 (sensu Tjernberg and Ursing) in an adult neurosurgical intensive care unit.

A. Troelstra, L. Dijkshoorn, S. Brisse, 2002, The Journal of hospital infection.

Distinguishing Species of the Burkholderia cepacia Complex and Burkholderia gladioli by Automated Ribotyping

P. Vandamme, A. van Belkum, B. Tümmler, 2000, Journal of Clinical Microbiology.

Determination of the Relationship between Group A Streptococcal Genome Content, M Type, and Toxic Shock Syndrome by a Mixed Genome Microarray (cid:1) †

L. Schouls, F. Schuren, M. Caspers, 2007 .

Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime.

A. Gillissen, J. Verhoef, 2003, International journal of antimicrobial agents.

Nosocomial Pneumonia

J. Verhoef, G. Andriesse, 2012, Treatments in respiratory medicine.

Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae.

J. Verhoef, D. Milatovic, W. Jansen, 2006, The Journal of antimicrobial chemotherapy.

Antimicrobial resistance among community-acquired pneumonia isolates in Europe: First results from the SENTRY antimicrobial surveillance program 1997

J. Verhoef, A. Fluit, Mark E. Jones, 1999 .

Antimicrobial resistance among community-acquired pneumonia isolates in Europe: first results from the SENTRY antimicrobial surveillance program 1997. SENTRY Participants Group.

J. Verhoef, A. Fluit, M. Jones, 1999, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis.

M. Rozenberg-Arska, J. Verhoef, C. Rademaker, 1990, The Journal of antimicrobial chemotherapy.

Failure To Control an Outbreak of qnrA1-Positive Multidrug-Resistant Enterobacter cloacae Infection despite Adequate Implementation of Recommended Infection Control Measures

A. Troelstra, J. Verhoef, H. Blok, 2007, Journal of Clinical Microbiology.

Cyclosporiasis Outbreak, Indonesia

M. Rozenberg-Arska, J. Verhoef, J. Verweij, 2005, Emerging infectious diseases.

Bacterial cell wall components decrease the number of guinea-pig lung beta-adrenoceptors.

J. Verhoef, F. Nijkamp, A. Schreurs, 1983, European journal of pharmacology.

Colonization and infection in surgical intensive care patients —a prospective study

J. Verhoef, J. H. Rommes, P. Wittebol, 2004, Intensive Care Medicine.

Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients

A. Graeff, M. Rozenberg-Arska, J. Verhoef, 1992, Antimicrobial Agents and Chemotherapy.

Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors

J. Verhoef, A. Fleer, H. van Dijk, 1994, Infection and immunity.

A decade of experience with selective decontamination of the digestive tract as prophylaxis for infections in patients in the intensive care unit: what have we learned?

M. Visser, J. Verhoef, E. Verhage, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Selective decontamination of the digestive tract for the prevention of infection.

J. Verhoef, 1993, International journal of antimicrobial agents.

The role of tumour necrosis factor in the kinetics of lipopolysaccharide‐mediated neutrophil priming in whole blood

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 2005, Clinical and experimental immunology.

Epitope Specificity ofRabbit Immunoglobulin G (IgG) Elicited by Pneumococcal Type23FSynthetic Oligosaccharide- andNative Polysaccharide-Protein

R. Feldman, J. Verhoef, J. Kamerling, 1994 .

Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism.

H. Balfour, J. Verhoef, P. Peterson, 1992, The Journal of clinical investigation.

Uncoupling of Oxidative and Non‐Oxidative Mechanisms in Human Granulocyte‐Mediated Cytotoxicity: Use of Cytoplasts and Cells From Chronic Granulomatous Disease Patient

J. Verhoef, A. Fluit, J. Strijp, 1990, Journal of leukocyte biology.

Human polymorphonuclear leukocytes release leukotriene B4 during phagocytosis ofStaphylococcus aureus

J. Verhoef, P. Henricks, F. Engels, 1986, Inflammation.

Partial removal of sialic acid enhances phagocytosis and the generation of superoxide and chemiluminescence by polymorphonuclear leukocytes.

J. Verhoef, P. Henricks, M. E. van Erne-van der Tol, 1982, Journal of immunology.

Effect of loracarbef and amoxicillin on the oropharyngeal and intestinal microflora of patients with bronchitis.

M. Rozenberg-Arska, J. Verhoef, M. Visser, 1994, Scandinavian journal of infectious diseases.

Detection of Candida spp. in blood cultures using nucleic acid sequence-based amplification (NASBA).

J. Verhoef, A. Fluit, M. L. Leverstein-van Hall, 2001, Diagnostic microbiology and infectious disease.

Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species.

J. Verhoef, B. van Gemen, A. Fluit, 1999, Journal of microbiological methods.

Development of a multiplex-PCR for direct detection of the genes for enterotoxin B and C, and toxic shock syndrome toxin-1 in Staphylococcus aureus isolates.

K. Köhrer, M. Steiert, J. Verhoef, 1998, Journal of medical microbiology.

Frequency of enterovirulentEscherichia coli in diarrhoeal disease in The Netherlands

J. Verhoef, C. Rademaker, A. Fluit, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Evidence for in-vivo transfer of mecA DNA between strains of Staphylococcus aureus

A. Troelstra, S. Brisse, J. Verhoef, 2001, The Lancet.

In-vivo transfer of mecA DNA to Staphylococcus aureus [corrected].

A. Troelstra, S. Brisse, J. Verhoef, 2001, Lancet.

Many Class I Integrons Comprise Distinct Stable Structures Occurring in Different Species ofEnterobacteriaceae Isolated from Widespread Geographic Regions in Europe

J. Verhoef, F. Schmitz, A. Fluit, 1999, Antimicrobial Agents and Chemotherapy.

Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds.

J. Verhoef, F. Schmitz, A. Fluit, 1998, The Journal of antimicrobial chemotherapy.

Beta-lactam antibiotics enhance the binding of antibodies to outer membrane, non-LPS antigenic structures in Enterobacteriaceae

J. Schellekens, M. Rozenberg-Arska, J. Verhoef, 1989 .

Functional microassay of complement activation by pneumococci

J. Verhoef, A. Fleer, P. Aerts, 1992 .

Comparative Evaluation of the BD Phoenix and VITEK 2 Automated Instruments for Identification of Isolates of the Burkholderia cepacia Complex

P. Vandamme, A. van Belkum, S. Brisse, 2002, Journal of Clinical Microbiology.

European Society of Clinical Microbiology

J. Verhoef, 1984, European Journal of Clinical Microbiology.

Transient immunodepression.

J. Verhoef, 1990, The Journal of antimicrobial chemotherapy.

Detection of enterovirulent Escherichia coli associated with diarrhoea in Seville, southern Spain, with non-radioactive DNA probes.

J. Verhoef, L. Martínez-Martínez, E. Perea, 1993, Journal of medical microbiology.

Increased Prevalence of Class I Integrons inEscherichia coli, Klebsiella Species, andEnterobacter Species Isolates over a 7-Year Period in a German University Hospital

K. Köhrer, J. Verhoef, A. Fluit, 2001, Journal of Clinical Microbiology.

Minimal oligosaccharide structures required for induction of immune responses against meningococcal immunotype L1, L2, and L3,7,9 lipopolysaccharides determined by using synthetic oligosaccharide-protein conjugates

G. A. van der Marel, J. Verhoef, G. Boons, 1991, Infection and immunity.

Enhanced binding of murine monoclonal antibodies to lipopolysaccharide structures of Enterobacteriaceae after treatment with antibiotics

M. Rozenberg-Arska, G. Raponi, J. Verhoef, 1989 .

Structural and functional changes of surfactant protein A induced by ozone.

M. V. van Greevenbroek, R. Oosting, J. Verhoef, 1991, The American journal of physiology.

Surfactant protein A is opsonin in phagocytosis of herpes simplex virus type 1 by rat alveolar macrophages.

J. Verhoef, J. V. van Strijp, M. Ebskamp, 1991, The American journal of physiology.

Evidence-based medicine in infectious diseases and microbiology: Still a long way to go

J. Verhoef, 2003, Current infectious disease reports.

The BCG controversy.

J. Verhoef, 1994, International journal of antimicrobial agents.

Plasminogen Activator Inhibitor 1: A New Prognostic Marker in Septic Shock

J. Schellekens, T. Calandra, M. Glauser, 1989, Thrombosis and Haemostasis.

Preparation, characterization, and immunogenicity of meningococcal immunotype L2 and L3,7,9 phosphoethanolamine group-containing oligosaccharide-protein conjugates

J. Verhoef, J. Poolman, P. Hoogerhout, 1991, Infection and immunity.

Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV

J. Verhoef, P. Peterson, P. Quie, 1977, Infection and immunity.

Effects oflysosomotropic amines on humanpolymorphonuclear leucocyte function

J. Verhoef, C. Vandenbroucke-Grauls, S. Sharma, 1984 .

Complement resistance is a virulence factor of Branhamella (Moraxella) catarrhalis.

J. Verhoef, A. Fleer, C. Verduin, 1995, FEMS immunology and medical microbiology.

Neutralization of Neisseria meningitidis outer membrane vesicles

A. Troelstra, J. Verhoef, P. Antal-Szalmás, 2011, Inflammation Research.

Binding of surfactant protein A to the lipid A moiety of bacterial lipopolysaccharides.

R. Oosting, J. Verhoef, J. V. van Strijp, 1994, The Biochemical journal.

Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.

J. Verhoef, H. Haagsman, L. V. Golde, 1990, American journal of respiratory cell and molecular biology.

A new procedure for the purification of streptococcal pyrogenic exotoxin A from Streptococcus pyogenes supernatant

J. Verhoef, S. Holm, H. van Dijk, 1996, Clinical and diagnostic laboratory immunology.

Analysis ofEscherichia coli isolates from subjects with travellers' diarrhoea using DNA probes and serotyping

M. Rozenberg-Arska, J. Verhoef, C. Rademaker, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization

H. Verbrugh, J. Verhoef, W. V. van Dijk, 1979, Infection and immunity.

Extensive Hospital-Wide Spread of a Multidrug-Resistant Enterobacter cloacae Clone, with Late Detection Due to a Variable Antibiogram and Frequent Patient Transfer

A. Troelstra, M. Bonten, J. Verhoef, 2006, Journal of Clinical Microbiology.

Comparison of Two Surveillance Methods for Detecting Nosocomial Infections in Surgical Patients

C. van der Werken, J. Verhoef, D. Beaujean, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Quantifying the relationship between Staphylococcus aureus bacteremia and S. aureus bacteriuria: a retrospective analysis in a tertiary care hospital.

M. Bonten, J. Verhoef, M. Ekkelenkamp, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

In-vitro selection of HIV-1 variants resistant to non-nucleoside reverse transcriptase inhibitors in monocyte-derived macrophages.

C. Boucher, J. Verhoef, R. Schuurman, 1997, The Journal of antimicrobial chemotherapy.

Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.

J. T. ten Cate, M. Daha, J. Verhoef, 1985, The Journal of infectious diseases.

Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals.

S. Geerlings, J. Verhoef, W. Gaastra, 1999, Journal of medical microbiology.

Mutations in GyrA, ParC, MexR and NfxB in clinical isolates of Pseudomonas aeruginosa.

J. Verhoef, P. Higgins, F. Schmitz, 2003, International journal of antimicrobial agents.

Opsonic defense to Staphylococcus epidermidis in the premature neonate.

J. Verhoef, A. Fleer, N. Westerdaal, 1985, The Journal of infectious diseases.

Effect of protein A on staphylococcal opsonization

J. Verhoef, P. Peterson, P. Quie, 1977, Infection and immunity.

Role of Healthcare Workers in Outbreaks of Methicillin-Resistant Staphylococcus aureus: A 10-Year Evaluation From a Dutch University Hospital

A. Troelstra, J. Verhoef, C. Vandenbroucke-Grauls, 2003, Infection Control & Hospital Epidemiology.

Rationalizing the Approach to Empirical Therapy

J. Verhoef, G. Andriesse, 2012 .

Long-term carriage, and transmission of methicillin-resistant Staphylococcus aureus after discharge from hospital.

J. Verhoef, C. Vandenbroucke-Grauls, H. M. Frénay, 1992, The Journal of hospital infection.

Clinical evaluation of a NASBA-based assay for detection of Candida spp. in blood and blood cultures.

J. Verhoef, A. Fluit, E. Boel, 2002, Clinical laboratory.

Epidemiology of Quinolone Resistance of Klebsiella pneumoniae and Klebsiella oxytoca in Europe

S. Brisse, J. Verhoef, F. Schmitz, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Methicillin-Resistant Staphylococcus Aureus Carriage Among Patients After Hospital Discharge

A. Troelstra, J. Verhoef, H. Blok, 2005, Infection Control & Hospital Epidemiology.

Development of Resistance to Ciprofloxacin, Rifampin, and Mupirocin in Methicillin-Susceptible and -ResistantStaphylococcus aureus Isolates

K. Köhrer, J. Verhoef, A. Fluit, 2000, Antimicrobial Agents and Chemotherapy.

Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice

J. Verhoef, M. Poppelier, K. V. van Kessel, 1996, Infection and immunity.

Protection against lethal endotoxemia by anti-lipid A murine monoclonal antibodies: comparison of efficacy with that of human anti-lipid A monoclonal antibody HA-1A.

A. Algra, J. Verhoef, J. Cornelissen, 1993, The Journal of infectious diseases.

Steady-state pharmacokinetics and sputum penetration of lomefloxacin in patients with chronic obstructive pulmonary disease and acute respiratory tract infections

J. Kovarik, M. Rozenberg-Arska, J. Verhoef, 1992, Antimicrobial Agents and Chemotherapy.

Pharmacokinetics of cefepime in patients with respiratory tract infections

J. T. ter Maaten, J. Kovarik, J. Verhoef, 1990, Antimicrobial Agents and Chemotherapy.

Double-blind, dose-range-finding study of fleroxacin (RO 23-6240; AM-833) for treatment of complicated urinary tract infections

J. Verhoef, M. Wolfhagen, A. Hoepelman, 1990, Antimicrobial Agents and Chemotherapy.

Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.

M. Rozenberg-Arska, J. Verhoef, J. Porsius, 1986, Journal of medical microbiology.

Binding of rough lipopolysaccharides (LPS) to human leukocytes. Inhibition by anti-LPS monoclonal antibody.

J. Verhoef, A. Weersink, J. V. van Strijp, 1990, Journal of immunology.

Monocyte infiltration is highly associated with loss of the tight junction protein zonula occludens in HIV‐1‐associated dementia

J. Verhoef, C. D. DE GROOT, L. Boven, 2000, Neuropathology and applied neurobiology.

Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strains.

J. Verhoef, A. Fleer, D. M. Jones, 1987, Journal of clinical pathology.

Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV‐1 replication

M. Visser, J. Verhoef, G. Rijkers, 1997, Clinical and experimental immunology.

Antibodies raised against rough mutants of Escherichia coli and Salmonella strains are opsonic only in the presence of complement

J. Verhoef, J. Marcelis, R. Vreede, 1986, Infection and immunity.

Monoclonal antibodies that react with live Listeria spp

J. Verhoef, R. Torensma, A. Fluit, 1993, Applied and environmental microbiology.

Multivalent binding of toxin A from Clostridium difficile to carbohydrate receptors.

J. Verhoef, M. Wolfhagen, R. Torensma, 1994, Toxicon : official journal of the International Society on Toxinology.

Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B

J. Verhoef, M. Wolfhagen, R. Torensma, 1991, Journal of clinical microbiology.

[Epidemic of methicillin-resistant Staphylococcus aureus due to the transfer of 2 Dutch burn patients from a hospital outside of the Netherlands; who suffers the consequences?].

A. Troelstra, J. Verhoef, E. Mascini, 2002, Nederlands tijdschrift voor geneeskunde.

The echinocandin caspofungin impairs the innate immune mechanism against Candida parapsilosis.

J. Verhoef, J. Scharringa, A. Hoepelman, 2009, International journal of antimicrobial agents.

CAPD, a Permanent State of Peritonitis: A Study on Peroxidase Activity

H. Verbrugh, J. Verhoef, R. Beelen, 1986 .

Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-α, interleukin-1β and interleukin-6

J. Verhoef, A. Fleer, H. Dijk, 1993 .

Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6.

J. Verhoef, A. Fleer, H. van Dijk, 1993, FEMS immunology and medical microbiology.

Effects of ozone on cellular ATP levels in rat and mouse alveolar macrophages.

R. Oosting, J. Verhoef, L. van Bree, 1991, Toxicology.

Virulence factors of genotyped bovine mastitis Staphylococcus aureus isolates in The Netherlands.

J. Verhoef, D. Mevius, A. Fluit, 2010 .

COLZ ANTIBODIES IN OPSONISATION AND PROTECTION AGAINST INFECTION

Der, J. Verhoef, H. A. Verbrugh, 2008 .

Phagocytic function of monocyte-derived macrophages is not affected by human immunodeficiency virus type 1 infection.

M. Visser, J. Verhoef, J. V. van Strijp, 1993, The Journal of infectious diseases.

Effect of human polymorphonuclear and mononuclear leukocytes on chromosomal and plasmid DNA of Escherichia coli. Role of acid DNase.

M. Rozenberg-Arska, J. Verhoef, W. P. Hoekstra, 1984, The Journal of clinical investigation.

Comparative activities of six different fluoroquinolones against 9,682 clinical bacterial isolates from 20 European university hospitals participating in the European SENTRY surveillance programme. The SENTRY participants group.

J. Verhoef, A. Fluit, F. Schmitz, 1999, International journal of antimicrobial agents.

Induction of cyclooxygenase‐2 expression during HIV‐1‐infected monocyte‐derived macrophage and human brain microvascular endothelial cell interactions

J. Verhoef, C. Pereira, L. Boven, 2000, Journal of leukocyte biology.

Interactions of surfactant protein A with influenza A viruses: binding and neutralization.

M. Harmsen, J. Verhoef, J. V. van Strijp, 1995, The Journal of infectious diseases.

Quantitation of surface CD14 on human monocytes and neutrophils

J. Verhoef, A. Weersink, P. Antal-Szalmás, 1997, Journal of leukocyte biology.

Surface hydrophobicity and opsonic requirements of coagulase-negative staphylococci in suspension and adhering to a polymer substratum

J. Verhoef, A. Fleer, N. Westerdaal, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Effect of influenza viras on phagocytic cells

H. Verbrugh, J. Verhoef, Y. Debets-Ossenkopp, 1982, European Journal of Clinical Microbiology.

Intracellular pathways involved in tumor necrosis factor-alpha release by human monocytes on stimulation with lipopolysaccharide or staphylococcal peptidoglycan are partly similar.

J. Verhoef, A. Fleer, K. V. van Kessel, 1996, The Journal of infectious diseases.

J Rollof factor alpha from human monocytes . induce differential release of tumor necrosis grown in the presence of different antibiotics Supernatants from Staphylococcus epidermidis

J. Verhoef, R. Norrby, H. Dijk, 1996 .

Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry

J. Verhoef, A. Verheul, J. Scharringa, 1995, Clinical and diagnostic laboratory immunology.

Characterisation and functional aspects of monoclonal antibodies specific for surface proteins of coagulase-negative staphylococci.

J. Verhoef, A. Fleer, R. Torensma, 1991, Journal of medical microbiology.

Role of mesothelial cells in peritoneal antibacterial defence.

H. Verbrugh, J. Verhoef, M. Muijsken, 1991, Journal of clinical pathology.

Trospectomycin enhances surface phagocytosis of Bacteroides and Staphylococcus by altering the bacterial glycocalyx.

D. A. Ferguson, J. Verhoef, D. Lambe, 1989, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Increased Expression of Leucocyte Adherence‐Related Glycoproteins by Polymorphonuclear Leucocytes during Phagocytosis of Staphylococci on an Endothelial Surface

J. Verhoef, E. Rozemuller, P. Tetteroo, 1989, Scandinavian journal of immunology.

Complement-mediated phagocytosis of herpes simplex virus by granulocytes. Binding or ingestion.

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 1989, The Journal of clinical investigation.

Phagocytosis of Bacteroides in suspension and on a glass surface determined by a modified fluorochrome assay

D. A. Ferguson, J. Verhoef, D. Lambe, 1989 .

Polynuclear iron complexes impair the function of polymorphonuclear granulocytes

J. Verhoef, J. Marx, I. Hoepelman, 1988, British journal of haematology.

The Opsonic Capacity of Monoclonal Antibodies Against Escherichia Coli 0111 and Its Rough Mutant E. Coli J5

J. Verhoef, R. Vreede, A. Bouter, 1988 .

Opsonization of Staphylococcus aureus protects endothelial cells from damage by phagocytosing polymorphonuclear leukocytes

J. Verhoef, C. Vandenbroucke-Grauls, H. M. Thijssen, 1987, Infection and immunity.

Injury to endothelial cells by phagocytosing polymorphonuclear leukocytes and modulatory role of lipoxygenase products

J. Verhoef, C. Vandenbroucke-Grauls, C. Vandenbroucke-Grauls, 1987, Infection and immunity.

Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process

J. Verhoef, E. Veringa, 1985, Antimicrobial Agents and Chemotherapy.

Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes

M. Rozenberg-Arska, J. Verhoef, J. V. van Strijp, 1985, Infection and immunity.

Phagocytosis of staphylococci by human polymorphonuclear leukocytes is enhanced in the presence of endothelial cells

J. Verhoef, C. Vandenbroucke-Grauls, H. M. Thijssen, 1985, Infection and immunity.

Cytotoxicity by human adherent cells oxygen dependent and independent cytotoxicity by different cell populations

M. Visser, J. Verhoef, J. Strijp, 1985 .

Phagocytic and chemotactic function of polymorphonuclear and mononuclear leucocytes in patients with recurrent staphylococcal infections.

H. Verbrugh, J. Verhoef, P. Peterson, 1980, Scandinavian journal of infectious diseases.

In vitro activity of faropenem against 5460 clinical bacterial isolates from Europe.

J. Verhoef, A. Fluit, D. Milatovic, 2002, The Journal of antimicrobial chemotherapy.

Antibiotics enhance binding of lipid A-specific murine monoclonal antibody E5 to Gram-negative bacteria.

J. Verhoef, J. Cornelissen, H. Snippe, 1994, International journal of antimicrobial agents.

Activation of Human Macrophages by Amyloid-β Is Attenuated by Astrocytes1

J. Verhoef, F. L. van Muiswinkel, A. V. van Beelen, 2001, The Journal of Immunology.

Activation of human macrophages by amyloid-beta is attenuated by astrocytes.

F. L. Muiswinkel, J. Verhoef, F. L. van Muiswinkel, 2001, Journal of immunology.

Protective effects of orally administered, Klebsiella-containing bacterial lysates in mice.

J. Verhoef, H. Bootsma, H. van Dijk, 1994, FEMS immunology and medical microbiology.

Differences in the effect of arachidonic acid on polymorphonuclear and mononuclear leukocyte function.

J. Verhoef, P. Henricks, F. Nijkamp, 1984, Biochimica et biophysica acta.

Exposure of surfactant protein A to ozone in vitro and in vivo impairs its interactions with alveolar cells.

R. Oosting, J. Verhoef, L. van Bree, 1992, The American journal of physiology.

Production of leukotriene B4 by polymorphonuclear leukocytes during phagocytosis ofStaphylococcus aureus

J. Verhoef, P. Henricks, Marijke E. van der Tol, 2005, Agents and Actions.

Natural occurring IgG and IgM antibodies to gram-negative bacteria and lipopolysaccharides in human sera

J. Schellekens, M. Rozenberg-Arska, J. Verhoef, 1988 .

Prevention of infections in granulocytopenic patients by fluorinated quinolones.

M. Rozenberg-Arska, J. Verhoef, A. Dekker, 1989, Reviews of infectious diseases.

Monoclonal antibodies specific for the phase-variant O-acetylated K1 capsule of Escherichia coli

M. Rozenberg-Arska, J. Verhoef, R. Torensma, 1991, Journal of clinical microbiology.

Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.

A. Troelstra, J. Verhoef, J. V. van Strijp, 1999, Journal of immunology.

Subsequent Binding Is Through CD 11 b / CD 18 Activate Human Neutrophils Via CD 14 While Lipopolysaccharide-Coated Erythrocytes

A. Troelstra, J. Verhoef, K. Kessel, 1999 .

Tumour necrosis factor triggers granulocytes to internalize complement-coated virus particles.

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 1991, Immunology.

Discrimination ofEpidemic andNonepidemic Methicillin- Resistant Staphylococcus aureus Strains ontheBasis ofProtein A GenePolymorphism

L. Schouls, J. Verhoef, C. Vandenbroucke-Grauls, 1994 .

Characterization and description of "Campylobacter upsaliensis" isolated from human feces

H. Goossens, J. Verhoef, K. Kersters, 1990, Journal of clinical microbiology.

Meningococcal lipopolysaccharide (LPS)-derived oligosaccharide-protein conjugates evoke outer membrane protein- but not LPS-specific bactericidal antibodies in mice: influence of adjuvants

J. Verhoef, E. Wiertz, J. Poolman, 1993, Infection and immunity.

The influence of the adjuvant Quil A on the epitope specificity of meningococcal lipopolysaccharide anti-carbohydrate antibodies.

J. Verhoef, J. Poolman, A. Verheul, 1991, Molecular immunology.

Compatibility of Peritoneal Dialysis Fluids Containing Alternative Osmotic Agents with Cells Present in the Peritoneal Cavity

A. Donker, H. Verbrugh, J. Verhoef, 1994 .

Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.

J. Verhoef, P. Peterson, P. Quie, 1977, The Journal of infectious diseases.

Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria.

J. Verhoef, P. Peterson, P. Quie, 1977, Journal of immunological methods.

Dialysis fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis

H. Verbrugh, J. Verhoef, J. V. D. Meulen, 1988, European Journal of Clinical Microbiology and Infectious Diseases.

Defective Complement-Mediated Opsonization and Lysis of Bacteria in Commercial Peritoneal Dialysis Solutions

H. Verbrugh, J. Verhoef, J. V. D. Meulen, 1986 .

The key role of peptidoglycan in the opsonization of Staphylococcus aureus.

J. Verhoef, S. Douglas, P. Peterson, 1978, The Journal of clinical investigation.

Propensity of Fluoroquinolones with Different Moieties at Position 8 to Cause Resistance Development in Clinical Isolates of Streptococcus pneumoniae

J. Verhoef, F. Schmitz, A. Fluit, 2001, Antimicrobial Agents and Chemotherapy.

Molecular epidemiology of quinolone resistance and comparative in vitro activities of new quinolones against European Staphylococcus aureus isolates.

K. Köhrer, S. Brisse, J. Verhoef, 1999, FEMS immunology and medical microbiology.

Frequency of Occurrence and Antimicrobial Susceptibility of Bacterial Pathogens Associated with Skin and Soft Tissue Infections During 1997 from an International Surveillance Programme

J. Verhoef, F. Schmitz, A. Fluit, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Relationship between ciprofloxacin, ofloxacin, levofloxacin, sparfloxacin and moxifloxacin (BAY 12-8039) MICs and mutations in grlA, grlB, gyrA and gyrB in 116 unrelated clinical isolates of Staphylococcus aureus.

K. Köhrer, J. Verhoef, A. Fluit, 1998, The Journal of antimicrobial chemotherapy.

Application of mucoadhesive in a colon inspection device

J. Verhoef, 2007 .

Chemotaxigenesis by cell surface components of Staphylococcus aureus

J. Verhoef, P. Peterson, P. Quie, 1979, Infection and immunity.

A New Report of Triclabendazole Efficacy during Invading Phase Fasciolasis

David N. Williams, J. Verhoef, P. Peterson, 1992 .

Immunology of Staphylococci

J. Verhoef, P. Peterson, P. Quie, 1981 .

In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci.

D. N. Williams, David N. Williams, J. Verhoef, 1978, The Journal of infectious diseases.

Effect of influenza virus on phagocytic cells.

H. Verbrugh, J. Verhoef, Y. Debets-Ossenkopp, 1982, European Journal of Clinical Microbiology.

The effect of influenza virus on oxygen-dependent metabolism of human neutrophils.

H. Verbrugh, J. Verhoef, Y. Debets-Ossenkopp, 1982, Advances in experimental medicine and biology.

Effect of iron on polymorphonuclear granulocyte phagocytic capacity: role of oxidation state and effect of ascorbic acid

J. Verhoef, I. Hoepelman, J. Marx, 1988, British journal of haematology.

In vitro stimulation of immune spleen cells enhances the number of anti-lipid A-producing hybridomas.

J. Verhoef, R. Torensma, B. Dekker, 1989, Journal of immunological methods.

In vivo TNF induction by culture supernatants of antibiotic-treated Escherichia coli 07:K1. Role of antibiotic class and concentration.

I. van der Tweel, J. Verhoef, A. Hoepelman, 1996, International journal of antimicrobial agents.

Surveillance of resistance against antimicrobial agents.

J. Verhoef, J. Acar, R. Jones, 1999, International journal of antimicrobial agents.

A randomized study to compare oral fluconazole to amphotericin B in the prevention of fungal infections in patients with acute leukaemia.

J. Verhoef, J. Branger, A. Dekker, 1991, The Journal of antimicrobial chemotherapy.

Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface

G. Raponi, J. Verhoef, N. Keller, 1990, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in Europe

J. Verhoef, D. Milatovic, W. Jansen, 2007, Antimicrobial Agents and Chemotherapy.

The use of a hybridization assay for the study of host defences against herpes simplex virus.

J. Verhoef, J. V. van Strijp, C. van Kessel, 1989, Journal of virological methods.

Interactions between HIV-infected monocyte-derived endothelial cells result in increased expression of CC chemokines

J. Verhoef, D. Schotte, E. Breij, 2000 .

Prevention of infections in granulocytopenic patients by fluorinated quinolones.

J. Verhoef, A. Dekker, M. Rozenberg‐Arska, 1991, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Prevention of bacterial and fungal infections in granulocytopenic patients.

J. Verhoef, A. Dekker, M. Rozenberg‐Arska, 1989, European journal of cancer & clinical oncology.

Role of peptidoglycan from Staphylococcus aureus in leukopenia, thrombocytopenia, and complement activation associated with bacteremia.

H. Verbrugh, J. Verhoef, J. Spika, 1982, The Journal of infectious diseases.

Complement and antibody enhance binding and uptake of HIV-1 by bone marrow cells.

J. G. van den Tweel, J. Verhoef, R. D. de Weger, 1994, Advances in experimental medicine and biology.

Infection of epithelial cell line HEp‐2 with human immunodeficiency virus type 1 is CD4 dependent

M. Visser, J. Verhoef, I. Janse, 1993, Journal of medical virology.

Human alveolar macrophage cytophilic immunoglobulin G-mediated phagocytosis of protein A-positive staphylococci.

H. Verbrugh, J. Verhoef, P. Peterson, 1982, The Journal of clinical investigation.

Biocompatibility of a glucose-polymer-containing peritoneal dialysis fluid.

A. Donker, H. Verbrugh, J. Verhoef, 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Opsonic recognition of staphylococci mediated by cell wall peptidoglycan: antibody-independent activation of human complement and opsonic activity of peptidoglycan antibodies.

M. Daha, H. Verbrugh, J. Verhoef, 1980, Journal of Immunology.

Human polymorphonuclear leucocyte receptors for staphylococcal opsonins.

J. Verhoef, P. Peterson, P. Quie, 1977, Immunology.

Opsonic requirements for staphylococcal phagocytosis. Heterogeneity among strains.

J. Verhoef, P. Peterson, P. Quie, 1977, Immunology.

Effect of influenza virus on phagocytic cell function

J. Verhoef, P. Henricks, C. Kessel, 1985, Antonie van Leeuwenhoek.

Interactions between Human Polymorphonuclear Leukocytes and Influenza Virus

J. Verhoef, P. Henricks, M. E. Tol, 1985, Scandinavian journal of immunology.

IN STAPHYLOCOCCAL DISEASE

H. Verbrugh, J. Verhoef, 1981 .

Modulation of Neutrophil Chemokine Receptors by Staphylococcus aureus Supernate

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 2000, Infection and Immunity.

Adjuvant Quil A improves protection in mice and enhances opsonic capacity of antisera induced by pneumococcal polysaccharide conjugate vaccines.

J. Verhoef, J. V. van Strijp, A. Verheul, 1994, Vaccine.

Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus.

J. Verhoef, B. Bouma, A. Timmerman, 1983, The Journal of infectious diseases.

Host-parasite interaction in serious infections due to gram-negative bacteria

J. Schellekens, J. Verhoef, R. Vreede, 2006, Antonie van Leeuwenhoek.

Pathogenesis of Gram-negative Bacterial Infections

J. Schellekens, J. Verhoef, 1988 .

Gram-Negative Bacterial Infections in the Critically Ill: Pathophysiological and Clinical Aspects

J. Verhoef, 1984 .

Host determinants in staphylococcal disease.

H. Verbrugh, J. Verhoef, 1981, Annual review of medicine.

Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes.

H. Verbrugh, J. Verhoef, P. Peterson, 1978, Journal of clinical pathology.

Neutrophil function, serum opsonic activity, and delayed hypersensitivity in surgical patients.

H. Verbrugh, J. Verhoef, W. V. van Dijk, 1982, Surgery.

Escherichia coli K antigen in relation to serum-induced lysis and phagocytosis.

H. Verbrugh, J. Verhoef, P. Peterson, 1979, Journal of medical microbiology.

Cross-reactivity of monoclonal antibodies against lipopolysaccharides of gram-negative bacteria

J. Verhoef, J. Marcelis, J. Jongh-Leuvenink, 1986, European Journal of Clinical Microbiology.

Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.

J. Sixma, J. Verhoef, A. Dekker, 1981, Annals of internal medicine.

The sepsis syndrome in a Dutch university hospital. Clinical observations.

J. Verhoef, W. Zhou, A. Hoepelman, 1993, Archives of internal medicine.

Induction of the early hypotensive phase by Escherichia coli: role of bacterial surface structures and inflammatory mediators.

J. Verhoef, F. Nijkamp, W. de Jong, 1985, The Journal of infectious diseases.

New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens

J. Verhoef, A. Fleer, Jan Verhoef, 2006, Antonie van Leeuwenhoek.

Surface Proteins of Coagulase-Negative Staphylococci: Their Role in Adherence to Biomaterials and in Opsonization

J. Verhoef, A. Fleer, J. Besnier, 1990, Journal of biomaterials applications.

Quantitation of the Third Component of Human Complement Attached to the Surface of Opsonized Bacteria: Opsonin-Deficient Sera and Phagocytosis-Resistant Strains

H. Verbrugh, J. Verhoef, P. Peterson, 1979, Infection and immunity.

Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9

J. Verhoef, S. Marzuki, D. Muljono, 2011, Archives of Virology.

The prevalence of aminoglycoside resistance and corresponding resistance genes in clinical isolates of staphylococci from 19 European hospitals.

J. Verhoef, F. Schmitz, A. Fluit, 1999, The Journal of antimicrobial chemotherapy.

Treatment of gram-negative septic shock with human IgG antibody to Escherichia coli J5: a prospective, double-blind, randomized trial.

J. Schellekens, T. Calandra, M. Glauser, 1988, The Journal of infectious diseases.

Presence of Integron-Associated Resistance in the Community Is Widespread and Contributes to Multidrug Resistance in the Hospital

J. Verhoef, H. Blok, A. Paauw, 2002, Journal of Clinical Microbiology.

Multi-resistance to antimicrobial agents for the ten most frequently isolated bacterial pathogens.

J. Verhoef, F. Schmitz, A. Fluit, 2001, International journal of antimicrobial agents.

Comparative Activities of Clinafloxacin, Grepafloxacin, Levofloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, and Trovafloxacin and Nonquinolones Linozelid, Quinupristin-Dalfopristin, Gentamicin, and Vancomycin against Clinical Isolates of Ciprofloxacin-Resistant and -Susceptible Staphylococcus aureu

M. Visser, J. Verhoef, P. Heisig, 1999, Antimicrobial Agents and Chemotherapy.

Susceptibility of 302 Methicillin-Resistant Staphylococcus aureus Isolates from 20 European University Hospitals to Vancomycin and Alternative Antistaphylococcal Compounds

J. Verhoef, A. Fluit, H. Heinz, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates

J. Verhoef, F. Schmitz, A. Fluit, 2003, Antimicrobial Agents and Chemotherapy.

Geographical distribution of quinolone resistance among Staphylococcus aureus, Escherichia coli and Klebsiella spp. isolates from 20 European university hospitals. SENTRY Participants Group.

J. Verhoef, F. Schmitz, A. Fluit, 1999, The Journal of antimicrobial chemotherapy.

A double-blind, placebo-controlled, parallel group study of oral trovafloxacin on bowel microflora in healthy male volunteers.

J. Verhoef, L. Purkins, S. Willavize, 1998, American journal of surgery.

Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection.

P. Portegies, J. Verhoef, M. Tardieu, 1999, Journal of immunology.

Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.

M. Bonten, M. Bonten, J. Verhoef, 2004, International journal of antimicrobial agents.

Protein A effect on alternative pathway complement activation and opsonization of Staphylococcus aureus

H. Verbrugh, J. Verhoef, J. Spika, 1981, Infection and immunity.

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

J. Verhoef, A. Dekker, M. Rozenberg‐Arska, 1987, Annals of internal medicine.

The influence of cefepime on opsonophagocytosis of bacteria.

G. Raponi, J. Verhoef, N. Keller, 1989, Drugs under experimental and clinical research.

Clindamycin at subinhibitory concentrations enhances antibody- and complement-dependent phagocytosis by human polymorphonuclear leukocytes of Staphylococcus aureus.

J. Verhoef, E. Veringa, 1987, Chemotherapy.

Clindamycin enhances opsonization of Staphylococcus aureus

J. Verhoef, D. Milatovic, I. Braveny, 1983, Antimicrobial Agents and Chemotherapy.

Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone

M. Visser, J. Verhoef, I. Hoepelman, 1991, Antimicrobial Agents and Chemotherapy.

Antibiotic sensitivity and synergism of 'penicillin-tolerant' Staphylococcus aureus.

J. Verhoef, L. Sabath, S. Duursma, 1979, Chemotherapy.

Proceedings: Netherlands Society for Microbiology meeting at Utrecht on 2 May 1973. The clearance of antibiotics by the artificial kidney.

J. Verhoef, S. Simonian, P. Oe, 1973, Antonie van Leeuwenhoek.

Tropical Diseases

J. Drazen, M. Skurnik, J. Verhoef, 2003, Advances in Experimental Medicine and Biology.

Novel Gene Cassettes and Integrons

J. Verhoef, A. Fluit, A. Box, 2001, Antimicrobial Agents and Chemotherapy.

Presence of Tetracycline Resistance Determinants and Susceptibility to Tigecycline and Minocycline

J. Verhoef, A. Fluit, D. Milatovic, 2005, Antimicrobial Agents and Chemotherapy.

Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests.

H Mittermayer, R Canton, F. Baquero, 2002, The Journal of antimicrobial chemotherapy.

Relationship between mutations in the coding and promoter regions of the norA genes in 42 unrelated clinical isolates of Staphylococcus aureus and the MICs of norfloxacin for these strains.

K. Köhrer, J. Verhoef, F. Schmitz, 1998, The Journal of antimicrobial chemotherapy.

Effect of iron on neonatal gut flora during the first three months of life

J. Verhoef, N. Vos, J. Marcelis, 1985, European Journal of Clinical Microbiology.

Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid

J. Verhoef, J. Marx, A. Struyvenberg, 1983, European Journal of Clinical Microbiology.

Carumonam (Ro 17-2301; AMA-1080) compared with gentamicin for treatment of complicated urinary tract infections

J. Verhoef, A. Hoepelman, L. Bakker, 1988, Antimicrobial Agents and Chemotherapy.

Infections in the immunocompromised host : pathogenesis, prevention, and therapy : proceedings of the First International Symposium on Infections in the Immunocomprised Host held in Veldhoven, The Netherlands, 1-5 June, 1980

J. Verhoef, P. Peterson, P. Quie, 1980 .

Open, randomized comparison of pefloxacin and cefotaxime in the treatment of complicated urinary tract infections

J. Verhoef, H. Mensink, I. Hoepelman, 2005, Infection.

Widespread occurrence of integrons causing multiple antibiotic resistance in bacteria

J. Verhoef, A. Fluit, Mark E. Jones, 1997, The Lancet.

The role of HSV-induced Fc- and C3b (i)-receptors in bacterial adherence.

J. Verhoef, T. T. ten Hagen, J. V. van Strijp, 1994, Journal of medical microbiology.

Characterization of a proteinaceous adhesin of Staphylococcus epidermidis which mediates attachment to polystyrene

J. Verhoef, A. Fleer, J. Besnier, 1991, Infection and immunity.

New criteria for antimicrobial therapy, maintenance of digestive tract colonization resistance : proceedings of a symposium, Utrecht, January 1979

J. Verhoef, D. Waaij, 1979 .

Rothia dentocariosa endocarditis complicated by an abdominal aneurysm.

J. Verhoef, A. Weersink, P. W. Westerhof, 1994, Clinical Infectious Diseases.

Integrons in Escherichia coli from food-producing animals in The Netherlands.

P. Schellen, J. Verhoef, D. Mevius, 2005, Microbial drug resistance.

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines

J. Verhoef, A. Verheul, H. Snippe, 1995, Microbiological reviews.

Overexpression of nerve growth factor and basic fibroblast growth factor in AIDS dementia complex

G. Jansen, P. Portegies, J. Verhoef, 1999, Journal of Neuroimmunology.

Influence of subinhibitory concentrations of Clindamycin on the phagocytosis of Staphylococcus aureus

J. Verhoef, E. Veringa, 1985 .

Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals.

L. Dijkshoorn, S. Brisse, J. Verhoef, 2004, Research in microbiology.

Identification of coagulase-negative staphylococci other than Staphylococcus epidermidis by automated ribotyping.

S. Brisse, J. Verhoef, I. Couto, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Frequency of Isolation of Pathogens from Bloodstream, Nosocomial Pneumonia, Skin and Soft Tissue, and Urinary Tract Infections Occurring in European Patients

J. Verhoef, F. Schmitz, A. Fluit, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance Determinants

J. Verhoef, A. Fluit, D. Milatovic, 2004, Antimicrobial Agents and Chemotherapy.

Protein-conjugated synthetic di- and trisaccharides of pneumococcal type 17F exhibit a different immunogenicity and antigenicity than tetrasaccharide.

G. Veeneman, J. Verhoef, J. V. van Boom, 1993, Vaccine.

mecA Gene Is Widely Disseminated in Staphylococcus aureus Population

F. J. Schmitz, S. Brisse, J. Verhoef, 2002, Journal of Clinical Microbiology.

Diversity and Evolution of the Class A Chromosomal Beta-Lactamase Gene in Klebsiella pneumoniae

S. Brisse, J. Verhoef, A. Paauw, 2004, Antimicrobial Agents and Chemotherapy.

Phagocytosis of herpes simplex virus by human granulocytes and monocytes

J. Verhoef, A. Fluit, J. Strijp, 2005, Archives of Virology.

Antimicrobial Resistance in European Isolates of Pseudomonas aeruginosa

J. Verhoef, F. Schmitz, A. Fluit, 2000, European Journal of Clinical Microbiology and Infectious Diseases.

Characterization of grlA, grlB, gyrA, and gyrB Mutations in 116 Unrelated Isolates of Staphylococcus aureus and Effects of Mutations on Ciprofloxacin MIC

K. Köhrer, J. Verhoef, A. Fluit, 1998, Antimicrobial Agents and Chemotherapy.

Comparison of E Test and Double Disk Diffusion Test for Detection of Extended Spectrum Beta-Lactamases

J. Verhoef, F. Schmitz, A. Fluit, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin

J. Verhoef, L. Verdonck, A. Dekker, 1989, Infection.

Evaluation of the Etest ESBL and the BD Phoenix, VITEK 1, and VITEK 2 Automated Instruments for Detection of Extended-Spectrum Beta-Lactamases in Multiresistant Escherichia coli and Klebsiella spp

Armand Paauw, Sylvain Brisse, S. Brisse, 2002, Journal of Clinical Microbiology.

Coagulase-negative staphylococci as nosocomial pathogens in neonates. The role of host defense, artificial devices, and bacterial hydrophobicity.

J. Verhoef, A. Fleer, Á. Pascual Hernández, 1986, The American journal of medicine.

Effect of chlorhexidine and acetic acid on phagocytosis by polymorphonuclear leucocytes

J. Verhoef, C. Lerk, J. J. Saene, 1985, European Journal of Clinical Microbiology.

Production of BRO β-Lactamases and Resistance to Complement in European Moraxella catarrhalis Isolates

K. Köhrer, J. Verhoef, A. Fluit, 2002, Journal of Clinical Microbiology.

The evolution of Pseudomonas aeruginosa during antibiotic rotation in a medical intensive care unit: the RADAR-trial.

C. van der Werken, J. Verhoef, A. Fluit, 2004, International journal of antimicrobial agents.

Evaluation of genetic determinants involved in beta-lactam- and multiresistance in a surgical ICU.

J. Verhoef, A. Fluit, A. Box, 2004, International journal of antimicrobial agents.

Inhibition by lipid A-specific monoclonal antibodies of priming of human polymorphonuclear leucocytes by endotoxin.

J. Verhoef, J. Cornelissen, C. van Kessel, 1991, Journal of medical microbiology.

In vitro activity of AZD2563, a novel oxazolidinone, against European Gram-positive cocci.

J. Verhoef, F. Schmitz, A. Fluit, 2002, The Journal of antimicrobial chemotherapy.

Intraprostatic distribution of lomefloxacin following multiple-dose administration

J. Kovarik, J. Verhoef, I. Hoepelman, 1990, Antimicrobial Agents and Chemotherapy.

Colistin and trimethoprim-sulfamethoxazole for the prevention of infection in patients with acute non-lymphocytic leukaemia. Decrease in the emergence of resistant bacteria

J. Verhoef, A. Dekker, M. Rozenberg‐Arska, 1983, Infection.

Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003.

J. Verhoef, A. Fluit, D. Milatovic, 2005, The Journal of antimicrobial chemotherapy.

Colonization and transmission of meticillin-susceptible and meticillin-resistant Staphylococcus aureus in a murine nasal colonization model.

I. B. Borel Rinkes, J. Verhoef, A. Fluit, 2011, Journal of medical microbiology.

Human fibronectin binding to staphylococcal surface protein and its relative inefficiency in promoting phagocytosis by human polymorphonuclear leukocytes, monocytes, and alveolar macrophages

H. Verbrugh, J. Verhoef, P. Peterson, 1981, Infection and immunity.

A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections.

J. Verhoef, A. Karperien, I. Hoepelman, 1995, International journal of antimicrobial agents.

Oral antibiotics as a novel therapy for arthritis: evidence for a beneficial effect of intestinal Escherichia coli.

W. Harmsen, L. Akkermans, M. Visser, 2000, Arthritis and rheumatism.

Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine

J. Verhoef, S. Marzuki, A. Hoepelman, 2015, Antimicrobial Agents and Chemotherapy.

Reduction in cytokine release from human monocytes by modifications in cell wall structure of Staphylococcus aureus induced by subinhibitory concentrations of oxacillin.

J. Verhoef, H. Heinz, U. Hadding, 1998, Journal of medical microbiology.

Identification of resistance and virulence factors in an epidemic Enterobacter hormaechei outbreak strain.

F. Schuren, M. Caspers, J. Verhoef, 2009, Microbiology.

Is Methicillin-Resistant Staphylococcus Aureus More Contagious than Methicillin-Susceptible S. Aureus in a Surgical Intensive Care Unit?

A. Troelstra, J. Verhoef, A. Fluit, 2002, Infection Control & Hospital Epidemiology.

Carumonam enhances reactivity of Escherichia coli with mono- and polyclonal antisera to rough Escherichia coli J5

J. Schellekens, J. Verhoef, B. Dekker, 1987, Journal of clinical microbiology.

Carumonam Enhances Reactivity of Escherichia coli with Mono-and Polyclonal Antisera to Rough Mutant Escherichia coli J 5

J. Schellekens, J. Verhoef, B. Dekker, 2022 .

Immunization of mice with antibiotic-treated Escherichia coli results in enhanced protection against challenge with homologous and heterologous bacteria.

G. Raponi, J. Verhoef, R. Torensma, 1991, The Journal of infectious diseases.

Escherichia coli antibodies in opsonisation and protection against infection.

H. Verbrugh, J. Verhoef, W. V. van Dijk, 1981, Journal of medical microbiology.

Serum-induced lysis ofPseudomonas aeruginosa

T. Meshulam, H. Verbrugh, J. Verhoef, 1982, European Journal of Clinical Microbiology.

Detection of antibodies against lipopolysaccharides of Escherichia coli and Salmonella R and S strains by immunoblotting

J. Verhoef, J. Marcelis, R. Vreede, 1985, Infection and immunity.

Prospects for monoclonal antibodies in the diagnosis and treatment of bacterial infections

J. Verhoef, R. Torensma, 1990, European Journal of Clinical Microbiology and Infectious Diseases.

Evaluation of protection by two endotoxin-neutralizing IgM monoclonal antibodies in different peritonitis models.

J. Verhoef, A. Hoepelman, T. Harmsen, 1997, Journal of Antimicrobial Chemotherapy.

Effect of imipenem on monoclonal antibody-mediated protection against Escherichia coli O18K5

J. Schellekens, J. Verhoef, K. V. van Kessel, 1996, Antimicrobial agents and chemotherapy.

The role of glycocalyx in surface phagocytosis of Bacteroides spp., in the presence and absence of clindamycin.

D. A. Ferguson, J. Verhoef, D. Lambe, 1989, Journal of Antimicrobial Chemotherapy.

Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations.

D. A. Ferguson, J. Verhoef, D. Lambe, 1989, Journal of Antimicrobial Chemotherapy.

The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences.

G. Raponi, J. Verhoef, N. Keller, 1989, The Journal of antimicrobial chemotherapy.

The effect of antisera on the induction of shock byE. coli

J. Verhoef, P. Henricks, F. Nijkamp, 1983, Agents and Actions.

Humoral immunity in human Gram-negative septic shock II. Specific anti-bacterial immunity: opsonic activity and the effect of intravenous immunoglobulin G administration

J. Schellekens, T. Calandra, J. Verhoef, 1989 .

Complement-mediated phagocytosis of Pseudomonas aeruginosa.

J. Verhoef, P. Peterson, P. Quie, 1978, The Journal of laboratory and clinical medicine.

Humoral immunity in human gram-negative septic shock. I: Potentially cross-protective anti-lipopolysaccharide antibodies

J. Schellekens, T. Calandra, J. Verhoef, 1989 .

Reactivity of monoclonal antibodies to Pseudomonas aeruginosa isolates from hospitalized adults and patients with cystic fibrosis.

J. Verhoef, R. Torensma, A. Fluit, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Opsonization and phagocytosis of mucoid and non-mucoidPseudomonas aeruginosa strains

T. Meshulam, H. Verbrugh, J. Verhoef, 1982, European Journal of Clinical Microbiology.

Changes in adherence of respiratory pathogens to HEp-2 cells induced by subinhibitory concentrations of sparfloxacin, ciprofloxacin, and trimethoprim

M. Visser, J. Verhoef, A. Hoepelman, 1993, Antimicrobial Agents and Chemotherapy.

Characters of phages from coagulase-negative staphylococci.

C. V. van Boven, J. Verhoef, K. Winkler, 1971, Journal of medical microbiology.

Enterovirulent Escherichia coli can cause bacteraemia in immunocompromised patients.

J. Verhoef, C. Rademaker, A. Fluit, 1993, The Journal of infection.

Effect of iron on neonatal gut flora during the first week of life

J. Verhoef, N. Vos, J. Marcelis, 1985, European Journal of Clinical Microbiology.

Deferoxamine enhances phagocytic function of human polymorphonuclear leukocytes.

J. Verhoef, B. S. van Asbeck, J. Marx, 1984, Blood.

Functional defects in phagocytic cells from patients with iron overload.

J. Verhoef, B. S. van Asbeck, J. Marx, 1984, The Journal of infection.

COMPARISON OF ONCE DAILY CEFTRIAXONE WITH GENTAMICIN PLUS CEFUROXIME FOR TREATMENT OF SERIOUS BACTERIAL INFECTIONS

J. Verhoef, I. Hoepelman, M. Rozenberg‐Arska, 1988, The Lancet.

Extracellular and bacterial factors influencing staphylococcal phagocytosis and killing by human polymorphonuclear leukocytes

J. Verhoef, P. Peterson, P. Quie, 1976, Infection and immunity.

Suppression of phagocytosis and chemotaxis by cell wall components of Staphylococcus aureus.

H. Verbrugh, J. Verhoef, D. Musher, 1981, Journal of immunology.

Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.

H. Verbrugh, J. Verhoef, P. Peterson, 1979, Immunology.

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines

J. Verhoef, A. Verheul, H. Snippe, 1995 .

Influence of fluoroquinolones on expression and function of P fimbriae in uropathogenic Escherichia coli

J. Kovarik, J. Verhoef, I. Hoepelman, 1989, Antimicrobial Agents and Chemotherapy.

Rosmarinic acid inhibits external oxidative effects of human polymorphonuclear granulocytes

J. Verhoef, K. Kessel, E. Kalter, 2005, Agents and Actions.

Discrimination by rabbit anti-idiotypic antibodies of two murine IgM monoclonal antibodies directed against lipid A.

J. Verhoef, J. Cornelissen, R. Torensma, 1990, Journal of immunological methods.

Issues in the adjunct therapy of severe sepsis.

J. Verhoef, A. Hoepelman, W. Hustinx, 1996, The Journal of antimicrobial chemotherapy.

Antibiotic Modulation of Host Defense

J. Verhoef, B. P. Overbeek, 1989 .

Binding characteristics and cross-reactivity of three different antilipid A monoclonal antibodies.

J. Verhoef, E. Brouwer, T. Erich, 1989, Journal of immunology.

Escherichia coli lipopolysaccharides diminish and enhance cell function of human polymorphonuclear leukocytes

J. Verhoef, P. Henricks, B. S. van Asbeck, 1983, Infection and immunity.

Escherichia coli in bacteremia: O-acetylated K1 strains appear to be more virulent than non-O-acetylated K1 strains

A. Algra, J. Verhoef, R. Torensma, 1993, Journal of clinical microbiology.

Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.

G. Raponi, J. Verhoef, N. Keller, 1991, Zentralblatt fur Bakteriologie : international journal of medical microbiology.

Clindamycin enhances complement-and antibody-dependent phagocytosis of Staphylococcus aureus by human polymorphonuclear granulocytes

J. Verhoef, Etèl Veringe, 1985, Antonie van Leeuwenhoek.

Tumor necrosis factor alpha (TNF-alpha) production in mice immunized with Escherichia coli: correlation with mortality after lethal challenge and production of a native inhibitor of TNF-alpha activity

G. Raponi, M. T. Lun, C. Mancini, 1993, Infection and immunity.

Influence of antibiotics on phagocytic defense

J. Verhoef, E. Veringa, 1985 .

Influence of Subinhibitory Concentrations of Clindamycin on Phagocytosis of S.Aureus

J. Verhoef, E. Veringa, 1987 .

Phage-typing of coagulase-negative staphylococci.

C. V. van Boven, J. Verhoef, K. Winkler, 1972, Journal of medical microbiology.

Lysogeny in coagulase-negative staphylococci.

C. V. van Boven, J. Verhoef, K. Winkler, 1971, Journal of medical microbiology.

Host-controlled modification and restriction of phages in coagulase-negative staphylococci.

C. V. van Boven, J. Verhoef, B. Holtrigter, 1972, Journal of general microbiology.

Deoxyribonucleic acid base composition of Staphylococcus epidermidis and its phages.

J. Verhoef, A. Hoff, A. van der Drift, 1971, Journal of general microbiology.

Binding of surfactant protein A (SP-A) to herpes simplex virus type 1-infected cells is mediated by the carbohydrate moiety of SP-A.

J. Verhoef, H. Haagsman, J. V. van Strijp, 1992, The Journal of biological chemistry.

A Dutch Approach to Methicillin-Resistant Staphylococcus aureus

C. van der Werken, J. Verhoef, D. Beaujean, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Prevalence of Aminoglycoside Resistance in 20 European University Hospitals Participating in the European SENTRY Antimicrobial Surveillance Programme

J. Verhoef, F. Schmitz, A. Fluit, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

Antibody and complement-binding activity of viable and nonviable human spermatozoa.

J. Verhoef, J. Kremer, E. Scheenjes, 1987, Archives of andrology.

Activation of polymorphonuclear leukocytes by spermatozoa.

J. Verhoef, F. R. Vogelpoel, 1985, Archives of andrology.

The phagocytic process and the role of complement in host defense.

J. Verhoef, 1991, Journal of chemotherapy.

Initiation of the respiratory burst of human neutrophils by influenza virus

H. Verbrugh, J. Verhoef, Y. Debets-Ossenkopp, 1981, Infection and immunity.

Iron and host defence

J. Verhoef, B. V. Asbeck, B. S. Asbeck, 1983, European Journal of Clinical Microbiology.

The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial overgrowth, and bacterial translocation in rats.

H. Gooszen, L. Akkermans, M. Visser, 1998, Annals of surgery.

In Vitro Development of Resistance to Six Quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus

K. Köhrer, J. Verhoef, P. Heisig, 2001, Antimicrobial Agents and Chemotherapy.

Lipoprotein metabolism in patients with severe sepsis

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 2003, Critical care medicine.

Antimicrobial activity of a multispecies probiotic (Ecologic 641) against pathogens isolated from infected pancreatic necrosis

H. Gooszen, J. Verhoef, H. Timmerman, 2007, Letters in applied microbiology.

Is Methicillin-Resistant Staphylococcus aureus More Contagious Than Methicillin-Susceptible S. aureus in a Surgical Intensive Care Unit?

A. Troelstra, C. van der Werken, J. Verhoef, 2002, Infection Control & Hospital Epidemiology.

Survival and Growth of Staphylococcus epidermidis within Phagocytes in Relation to Recurrent Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients

A. Donker, H. Verbrugh, J. Verhoef, 1990 .

Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin

J. Verhoef, J. Marcelis, B. V. Asbeck, 1983, European Journal of Clinical Microbiology.

Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection.

C. Boucher, M. Visser, J. Verhoef, 1998, The Journal of infectious diseases.

Attachment of human polymorphonuclear leukocytes to herpes simplex virus-infected fibroblasts mediated by antibody-independent complement activation

J. Verhoef, J. V. van Strijp, A. Fluit, 1988, Journal of Virology.

Host — parasite relationship in staphylococcal infections: the role of the staphylococcal cell wall during the process of phagocytosis

H. Verbrugh, J. Verhoef, P. Peterson, 2004, Antonie van Leeuwenhoek.

Limiting factors in bacterial phagocytosis by human polymorphonuclear leukocytes.

J. Verhoef, B. Björkstén, P. Peterson, 2009, Acta pathologica et microbiologica Scandinavica. Section C, Immunology.

Influence of temperature on opsonization and phagocytosis of staphylococci

J. Verhoef, P. Peterson, P. Quie, 1977, Infection and immunity.

Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.

J. Verhoef, F. Schmitz, A. Fluit, 2004, International journal of antimicrobial agents.

Measurement of antibody-mediated binding of human polymorphonuclear leukocytes to HSV-1 infected anchorage fibroblasts.

M. Visser, J. Verhoef, J. V. van Strijp, 1986, Journal of immunological methods.

Molecular typing of methicillin-resistantStaphylococcus aureus on the basis of protein A gene polymorphism

F. Mooi, L. Schouls, J. Verhoef, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family.

W. Kuis, M. Daha, H. Verbrugh, 1983, Pediatrics.

Modulation of phagocytic cell function

J. Verhoef, P. Henricks, F. Nijkamp, 1986, Veterinary Research Communications.

Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload.

B. V. van Oost, H. Verbrugh, J. Verhoef, 1982, British medical journal.

A brief history of the pneumococcus in biomedical research: a panoply of scientific discovery.

D. Musher, J. Verhoef, J. W. Jacobson, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virulence of staphylococci in neonatal mice

J. Verhoef, J. Graaff, F. Namavar, 2007, Antonie van Leeuwenhoek.

What action should be taken to prevent spread of vancomycin resistant enterococci in European hospitals?

M. Bonten, J. Verhoef, E. Mascini, 2002, BMJ : British Medical Journal.

Defects of phagocytic cells in patients with iron overload

J. Verhoef, J. Marx, A. Struyvenberg, 1982, Antonie van Leeuwenhoek.

International comparative study of cefepime and ceftazidime in the treatment of serious bacterial infections.

S. Gillespie, J. Verhoef, F. Meunier, 1993, The Journal of antimicrobial chemotherapy.

Bacteriophage typing of coagulase-negative staphylococci

J. Verhoef, C. P. V. Boven, K. Winkler, 2005, Antonie van Leeuwenhoek.

Clinical Efficacy and Morbidity Associated with Continuous Cyclic Compared with Continuous Ambulatory Peritoneal Dialysis

A. Donker, H. Verbrugh, J. Verhoef, 1994, Annals of Internal Medicine.

Effects of lysosomotropic amines on human polymorphonuclear leucocyte function.

J. Verhoef, C. Vandenbroucke-Grauls, S. Sharma, 1984, Immunology.

Cardiopulmonary bypass and host defense functions in human beings: I. Serum levels and role of immunoglobulins and complement in phagocytosis.

H. Verbrugh, J. Verhoef, B. Zegers, 1985, The Annals of thoracic surgery.

Rapid detection of toxigenic Clostridium difficile in fecal samples by magnetic immuno PCR assay

J. Verhoef, M. Wolfhagen, R. Torensma, 1994, Journal of clinical microbiology.

Multiple mutations conferring ciprofloxacin resistance in Staphylococcus aureus demonstrate long-term stability in an antibiotic-free environment.

K. Köhrer, J. Verhoef, M. Jones, 2000, The Journal of antimicrobial chemotherapy.

Antibodies and complement enhance binding and uptake of HIV‐1 by human monocytes

M. Visser, J. Verhoef, J. V. van Strijp, 1992, AIDS.

An evaluation of the role of surface hydrophobicity and extracellular slime in the pathogenesis of foreign-body-related infections due to coagulase-negative staphylococci.

J. Verhoef, A. Fleer, 1989, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

Serum Amyloid P Component Bound to Gram-Negative Bacteria Prevents Lipopolysaccharide-Mediated Classical Pathway Complement Activation

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 2000, Infection and Immunity.

Host defence to bacterial infection in the neonate.

J. Verhoef, A. Fleer, L. Gerards, 1988, The Journal of hospital infection.

Interactions between HIV-infected monocyte-derived macrophages and human brain microvascular endothelial cells result in increased expression of CC chemokines.

J. Verhoef, D. Schotte, J. Verhoef, 2000, Journal of neurovirology.

Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages.

S. Brisse, M. Tibayrenc, J. Verhoef, 2001, International journal for parasitology.

In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.

A. Donker, H. Verbrugh, J. Verhoef, 1993, Clinical nephrology.

Detection of toxigenicClostridium difficile in fecal samples by colony blot hybridization

J. Verhoef, M. Wolfhagen, C. Rademaker, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Genes and spectrum : The theoretical limits. Discussion

J. Quinn, I. Phillips, F. Baquero, 1998 .

diffusion tests for the detection of Extended Spectrum Beta-Lactamases (ESBLs)

J. Verhoef, A. Fluit, S. Nijssen, 2002 .

Comparison of typing methods for Clostridium difficile isolates

J. Verhoef, M. Wolfhagen, R. Torensma, 1993, Journal of clinical microbiology.

Occurrence and spread of SHV extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in Curacao.

S. Brisse, J. Verhoef, A. Paauw, 2003, The Journal of antimicrobial chemotherapy.

Another reason to restrict the use of a hypertonic, glucose-based peritoneal dialysis fluid: its impact on peritoneal macrophage function in vivo.

A. Donker, H. Verbrugh, J. Verhoef, 1991, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Host defence in CAPD treatment: the effect of the dialysate on cell function.

H. Verbrugh, J. Verhoef, J. van der Meulen, 1990, Contributions to Nephrology.

Cytotoxic Effects of Commercial Continuous Ambulatory Peritoneal Dialysis (CAPD) Fluids and of Bacterial Exoproducts on Human Mesothelial Cells in Vitro

H. Verbrugh, J. Verhoef, J. van der Meulen, 1989, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo.

A. Donker, H. Verbrugh, J. Verhoef, 1991, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Antibacterial peritoneal defence in automated peritoneal dialysis: advantages of tidal over continuous cyclic peritoneal dialysis?

A. Donker, H. Verbrugh, J. Verhoef, 1994, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function.

H. Verbrugh, J. Verhoef, H. F. Brulez, 1994, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis.

M. Visser, J. Verhoef, A. Fleer, 1983, Pediatric infectious disease.

In Vitro Activities of Sitafloxacin (DU-6859a) and Six Other Fluoroquinolones against 8,796 Clinical Bacterial Isolates

S. Brisse, J. Verhoef, A. Fluit, 2000, Antimicrobial Agents and Chemotherapy.

RESTRICTION AND MODIFICATION OF PHAGES IN STAPHYLOCOCCAL PHAGE TYPING

J. Verhoef, C. P. V. Boven, E. Stobberingh, 1974 .

Treatment Options for Streptococcus pneumoniae Strains Resistant to Macrolides, Tetracycline, Quinolones, or Trimethoprim/Sulfamethoxazole

J. Verhoef, F. Schmitz, A. Fluit, 2001, European Journal of Clinical Microbiology & Infectious Diseases.

In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis.

J. Verhoef, F. Schmitz, A. Fluit, 2002, The Journal of antimicrobial chemotherapy.

In vitro activity of faropenem and 20 other compounds against beta-lactamase-positive and -negative Moraxella catarrhalis and Haemophilus influenzae isolates and the effect of serum on faropenem MICs.

J. Verhoef, F. Schmitz, A. Fluit, 2002, The Journal of antimicrobial chemotherapy.

In vitro activity of faropenem and 21 other compounds against 385 different genetically characterized isolates of antibiotic-resistant Streptococcus pneumoniae.

J. Verhoef, F. Schmitz, A. Fluit, 2001, The Journal of antimicrobial chemotherapy.

Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea

J. Verhoef, M. Wolfhagen, C. Rademaker, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

In vitro potency of moxifloxacin, clinafloxacin and sitafloxacin against 248 genetically defined clinical isolates of Staphylococcus aureus.

S. Brisse, J. Verhoef, A. Fluit, 2000, Journal of Antimicrobial Chemotherapy.

Comparative In Vitro Activities of Ciprofloxacin, Clinafloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, and Trovafloxacin againstKlebsiella pneumoniae, Klebsiella oxytoca,Enterobacter cloacae, and Enterobacter aerogenes Clinical Isolates with Alterations in GyrA and ParC Proteins

K. Köhrer, S. Brisse, J. Verhoef, 1999, Antimicrobial Agents and Chemotherapy.

The stability of grlA, grlB, gyrA, gyrB and norA mutations and MIC values of five fluoroquinolones in three different clonal populations of methicillin-resistant Staphylococcus aureus.

K. Köhrer, J. Verhoef, A. Fluit, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Safety and efficacy of lomefloxacin versus norfloxacin in the treatment of complicated urinary tract infections

M. Visser, J. Verhoef, I. Hoepelman, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Prostatitis due to penicillinase-producing Neisseria gonorrhoeae: Case reports

J. Verhoef, C. Vandenbroucke-Grauls, C. Hengst, 1982, The British journal of venereal diseases.

Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338)

M. Visser, J. Verhoef, I. Hoepelman, 1989, European Journal of Clinical Microbiology and Infectious Diseases.

Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis.

J. Verhoef, C. Vandenbroucke-Grauls, W. V. van Wamel, 1998, FEMS microbiology letters.

Delta-toxin from Staphylococcus aureus as a costimulator of human neutrophil oxidative burst.

J. Verhoef, J. V. van Strijp, F. Schmitz, 1997, The Journal of infectious diseases.

The amino-terminus of the amyloid-β protein is critical for the cellular binding and consequent activation of the respiratory burst of human macrophages

P. Eikelenboom, F. L. Muiswinkel, J. Verhoef, 1999, Journal of Neuroimmunology.

Resistance to tetracycline and distribution of tetracycline resistance genes in European Staphylococcus aureus isolates.

J. Verhoef, F. Schmitz, A. Fluit, 2001, The Journal of antimicrobial chemotherapy.

TumorNecrosis Factor Alpha(TNF-a) Production inMice Immunized withEscherichia coli: Correlation withMortality after Lethal Challenge andProduction ofa Native Inhibitor ofTNF-(xActivity

G. Raponi, M. T. Lun, C. Mancini, 1993 .

The role of cytokines in gram-positive bacterial shock.

J. Verhoef, E. Mattsson, 1995, Trends in microbiology.

Induction of TNF-alpha in human peripheral blood mononuclear cells by the mannoprotein of Cryptococcus neoformans involves human mannose binding protein.

J. Verhoef, A. Hoepelman, A. Verheul, 1997, Journal of immunology.

Enhanced expression of fractalkine in HIV-1 associated dementia

G. Jansen, J. Verhoef, C. Pereira, 2001, Journal of Neuroimmunology.

Clinical significance of Clostridium difficile and its toxins in faeces of immunocompromised children.

J. Verhoef, M. Wolfhagen, A. Fleer, 1994, Gut.

Temporal trends in the population structure of Bordetella pertussis during 1949-1996 in a highly vaccinated population.

F. Mooi, N. Nagelkerke, J. Verhoef, 1999, The Journal of infectious diseases.

Determination of the Relationship between Group A Streptococcal Genome Content, M Type, and Toxic Shock Syndrome by a Mixed Genome Microarray

L. Schouls, F. Schuren, M. Caspers, 2007, Infection and Immunity.

Differences in spontaneously reported hypersensitivity and serious adverse events for intravenous iron preparations: comparison of Europe and North America

W. Hörl, G. Bailie, J. Verhoef, 2011, Arzneimittelforschung.

Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.

J. Verhoef, P. Elsbach, J. Weiss, 1993, Journal of immunology.

Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells

J. Verhoef, A. Hoepelman, J. Scharringa, 2008, BMC Microbiology.

Differences in the reporting rates of serious allergic adverse events from intravenous iron by country and population.

G. Bailie, J. Verhoef, 2012, Clinical advances in hematology & oncology : H&O.

Effect of iron (III) in the presence of various ligands on the phagocytic and metabolic activity of human polymorphonuclear leukocytes.

J. Verhoef, B. S. van Asbeck, J. Marx, 1984, Journal of immunology.

Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis

N. V. van Nuland, J. Verhoef, A. D. de Jong, 2005, FEBS letters.

Yersiniabactin Reduces the Respiratory Oxidative Stress Response of Innate Immune Cells

J. Verhoef, A. Paauw, A. Fluit, 2009, PloS one.

Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada

J. Verhoef, D. Milatovic, W. Jansen, 2008, Current medical research and opinion.

J. Verhoef, M. Pfaller, G. Doern, 2000, Microbial drug resistance.

Surveillance study of the susceptibility of Haemophilus influenzae to various antibacterial agents in Europe and Canada.

J. Verhoef, D. Milatovic, W. Jansen, 2008, Current medical research and opinion.

Enhancement of human natural killer cell activity by subcellular components of Toxoplasma gondii.

J. Verhoef, J. Remington, S. Sharma, 1984, Cellular immunology.

Microbiologic risk of invasive hemodynamic monitoring in patients undergoing open‐heart operations

J. Verhoef, J. Damen, D. Bolton, 1985, Critical care medicine.

Costs Associated with a Strict Policy to Eradicate Methicillin-Resistant Staphylococcus aureus in a Dutch University Medical Center: A 10-Year Survey

A. Troelstra, C. van der Werken, J. Verhoef, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Five-year surveillance of patients with communicable diseases nursed in isolation.

J. Verhoef, D. Beaujean, H. Blok, 2001, The Journal of hospital infection.

Discrimination of Klebsiella pneumoniae and Klebsiella oxytoca phylogenetic groups and other Klebsiella species by use of amplified fragment length polymorphism.

S. Brisse, J. Verhoef, F. Daschner, 2004, Research in microbiology.

, Jan Verhoef , Alex Van Complex cepacia Burkholderia Identification of Isolates of the and VITEK 2 Automated Instruments for Comparative Evaluation of the BD Phoenix

P. Vandamme, S. Brisse, J. Verhoef, 2002 .

Molecular epidemiology of penicillin-resistant Streptococcus pneumoniae colonizing children with community-acquired pneumonia and children attending day-care centres in Fortaleza, Brazil.

S. Brisse, J. Verhoef, A. Fleer, 2000, The Journal of antimicrobial chemotherapy.

Damage to chromosomal and plasmid DNA by toxic oxygen species.

J. Verhoef, B. S. van Asbeck, M. Rozenberg‐Arska, 1985, Journal of general microbiology.

The influence of flucloxacillin and amoxicillin with clavulanic acid on the aerobic flora of the alimentary tract

J. Verhoef, F. Vlaspolder, G. Zeeuw, 1987, Infection.

Genomic Diversity within the Enterobacter cloacae Complex

F. Schuren, M. Caspers, J. Verhoef, 2008, PloS one.

Chemiluminescence of human polymorphonuclear leucocytes after stimulation with whole cells and cell-wall components of Staphylococcus epidermidis.

J. Verhoef, L. Martínez-Martínez, A. Fleer, 1993, Journal of medical microbiology.

Inhibition of human natural killer activity by lysosomotropic agents.

J. Verhoef, S. Sharma, 1983, Journal of immunology.

Staphylococcal Culture Supernates Stimulate Human Phagocytes

J. Verhoef, J. V. van Strijp, K. V. van Kessel, 1997, Inflammation.

Host-pathogen relationships in respiratory tract infections.

J. Verhoef, 1991, Clinical therapeutics.

C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients

J. Verhoef, I. Hoepelman, P. C. Ligtenberg, 2005, European Journal of Clinical Microbiology and Infectious Diseases.

Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.

J. Verhoef, A. Dekker, M. Rozenberg‐Arska, 1987, Haematology and blood transfusion.

In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status.

J. Verhoef, A. Fluit, S. Schwarz, 2002, The Journal of antimicrobial chemotherapy.

Acquisition and Duration of Vancomycin-Resistant Enterococcal Carriage in Relation to Strain Type

A. Troelstra, M. Bonten, J. Verhoef, 2003, Journal of Clinical Microbiology.

Specific information concerning taxonomy, pathogenicity and methicillin resistance of staphylococci obtained by a multiplex PCR.

K. Köhrer, J. Verhoef, B. Hofmann, 1997, Journal of medical microbiology.

Detection of staphylococcal genes directly from cerebrospinal and peritoneal fluid samples using a multiplex polymerase chain reaction

M. Steiert, J. Verhoef, A. Fluit, 1998, European Journal of Clinical Microbiology and Infectious Diseases.

Comparative Activity of 27 Antimicrobial Compounds Against 698 Streptococcus pneumoniae Isolates Originating from 20 European University Hospitals

J. Verhoef, F. Schmitz, A. Fluit, 1999, European Journal of Clinical Microbiology and Infectious Diseases.

, R polysaccharide conjugate vaccines . act as carriers in pneumococcal Synthetic peptides representing T-cell epitopes

W. van Eden, J. Verhoef, R. van der Zee, 1994 .

Association of Alterations in ParC and GyrA Proteins with Resistance of Clinical Isolates of Enterococcus faecium to Nine Different Fluoroquinolones

K. Köhrer, S. Brisse, J. Verhoef, 1999, Antimicrobial Agents and Chemotherapy.

Influence of polymorphonuclear granulocytes on the zona-free hamster oocyte assay.

J. Verhoef, R. V. van Kooij, E. T. te Velde, 1991, Human reproduction.

APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.

J. Paridaen, J. Verhoef, C. Pereira, 2003, The Journal of antimicrobial chemotherapy.

Airborne gram-negative bacteria and endotoxin in sick building syndrome. A study in Dutch governmental office buildings.

J. Verhoef, C. Vandenbroucke-Grauls, J Verhoef, 1994, Archives of internal medicine.

N‐acetyl‐L‐cysteine‐induced up‐regulation of HIV‐1 gene expression in monocyte‐derived macrophages correlates with increased NF‐κB DNA binding activity

M. Visser, J. Verhoef, H. Nottet, 1997, Journal of leukocyte biology.

Comparison of immunomagnetic beads coated with protein A, protein G, or goat anti-mouse immunoglobulins. Applications in enzyme immunoassays and immunomagnetic separations.

J. Verhoef, R. Torensma, A. Fluit, 1993, Journal of immunological methods.

Degradation of herpes simplex virions by human polymorphonuclear leukocytes and monocytes.

J. Verhoef, J. V. van Strijp, A. Fluit, 1990, The Journal of general virology.

Cellular aspects of HIV‐1 infection of macrophages leading to neuronal dysfunction in in vitro models for HIV‐1 encephalitis

J. Verhoef, L. Boven, H. Nottet, 1997, Journal of leukocyte biology.

Evolution in Quantum Leaps: Multiple Combinatorial Transfers of HPI and Other Genetic Modules in Enterobacteriaceae

J. Verhoef, A. Paauw, A. Fluit, 2010, PloS one.

Acute lymphoblastic leukaemia patients treated with PEGasparaginase develop antibodies to PEG and the succinate linker

W. Hennink, E. Mastrobattista, J. Verhoef, 2019, British journal of haematology.

Frequency of Isolation and Antimicrobial Resistance of Gram-Negative and Gram-Positive Bacteria from Patients in Intensive Care Units of 25 European University Hospitals Participating in the European Arm of the SENTRY Antimicrobial Surveillance Program 1997–1998

J. Verhoef, F. Schmitz, A. Fluit, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Antibody mediated enhancement of HIV‐1 infection of an EBV transformed B cell line is CD4 dependent

M. Visser, J. Verhoef, I. Janse, 1992, European journal of clinical investigation.

Neuropathogenesis of HIV-1 Infection Dementia Complex : Implications for the Increased Peroxynitrite Activity in AIDS

Gray, P. Portegies, J. Verhoef, 1999 .

Moraxella catarrhalis in acute laryngitis: infection or colonization?

J. Verhoef, A. Fleer, C. Verduin, 1996, The Journal of infectious diseases.

Typing of 154 clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and determination of the in vitro susceptibilities of these strains to 28 antibiotics.

J. Verhoef, F. Schmitz, A. Fluit, 2000, The Journal of antimicrobial chemotherapy.

Establishment of a European network for the surveillance of Mycobacterium tuberculosis, MRSA and penicillin-resistant pneumococci.

F. Mooi, M. Steiert, D. van Soolingen, 1996, The Journal of antimicrobial chemotherapy.

Pharmacokinetics of the new penicillins. Amoxycillin and flucloxacillin in patients with terminal renal failure undergoing haemodialysis.

J. Verhoef, S. Simonian, P. Oe, 1973 .

Determining risk factors for methicillin-resistant Staphylococcus aureus carriage after discharge from hospital.

J. Verhoef, D. Beaujean, H. Blok, 1999, The Journal of hospital infection.

Antimicrobial Therapy in Patients on Haemodialysis

J. Verhoef, P. Oe, 1976 .

Aging and Antimicrobial Therapy

J. Verhoef, P. Oe, 1976 .

A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections.

J. Verhoef, A. Hoepelman, J. V. van Helmond, 1993, The Journal of antimicrobial chemotherapy.

Antibodies to cell wall peptidoglycan of Staphylococcus aureus in patients with serious staphylococcal infections.

H. Verbrugh, J. Verhoef, P. Peterson, 1981, The Journal of infectious diseases.

Antimicrobial activity of gatifloxacin (AM-1155, CG5501), and four other fluoroquinolones tested against 2,284 recent clinical strains of Streptococcus pneumoniae from Europe, Latin America, Canada, and the United States. The SENTRY Antimicrobial Surveillance Group (Americas and Europe).

J. Verhoef, R. Jones, A. Fluit, 1999, Diagnostic microbiology and infectious disease.

Pharmacokinetics of cefepime in patients with the sepsis syndrome.

J. Verhoef, A. Hoepelman, A. van Dijk, 1993, Journal of Antimicrobial Chemotherapy.

Antibiotic rotation and development of gram-negative antibiotic resistance.

A. Troelstra, M. Bonten, C. van der Werken, 2005, American journal of respiratory and critical care medicine.

[Urinary tract infection in the elderly; what does it mean?].

J. Verhoef, M. Wolfhagen, I. Hoepelman, 1990, Nederlands tijdschrift voor geneeskunde.

Species differences in impairment and recovery of alveolar macrophage functions following single and repeated ozone exposures.

R. Oosting, J. Verhoef, L. van Bree, 1991, Toxicology and applied pharmacology.

hydroxylase expression in malignant and normal colon tissue from eight participants

A. Troelstra, M. Holick, J. Flanagan, 2001 .

Impairment of phagocytic functions of alveolar macrophages by hydrogen peroxide.

R. Oosting, J. Verhoef, L. van Bree, 1990, The American journal of physiology.

Bacteroides and Staphylococcus glycocalyx: chemical analysis, and the effects on chemiluminescence and chemotaxis of human polymorphonuclear leucocytes.

J. Verhoef, W. Mayberry, D. Lambe, 1992, Microbios.

Do quinolones really augment the antifungal effect of amphotericin B in vitro?

J. Verhoef, B. P. Overbeek, M. Rozenberg‐Arska, 1985, Drugs under experimental and clinical research.

Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group.

R. Heyderman, J. Verhoef, P. Mason, 1997, The Journal of infectious diseases.

Serum-independent binding of lipopolysaccharide to human monocytes is trypsin sensitive and does not involve CD14.

J. Verhoef, A. Weersink, K. V. van Kessel, 1993, Immunology.

Intracellular pathways involved in TNF-alpha and superoxide anion release by Abeta(1-42)-stimulated primary human macrophages.

J. Verhoef, T. van der Bruggen, H. A. Smits, 2001, Journal of neuroimmunology.

Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old.

J. Verhoef, A. Fleer, L. Rey, 1999, Annals of tropical paediatrics.

A Pilot Study on Infection Control in 10 Randomly Selected European Hospitals: Results of a Questionnaire Survey

A. Troelstra, J. Verhoef, A. Weersink, 2000, Infection Control & Hospital Epidemiology.

Interaction between ciprofloxacin and tobramycin or azlocillin against multiresistant strains ofAcinetobacter anitratum in vitro

J. Verhoef, B. P. Overbeek, M. Rozenberg‐Arska, 1985, European Journal of Clinical Microbiology.

Antimicrobial susceptibility of coagulase-negative staphylococci isolated between 1991 and 1996 from a German university hospital.

J. Verhoef, A. Fluit, H. Heinz, 1999, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Impact of hygienic measures on the development of methicillin resistance among staphylococci between 1991 and 1996 in a university hospital.

J. Verhoef, H. Idel, H. Heinz, 1998, The Journal of hospital infection.

Within-Host Selection of Drug Resistance in a Mouse Model Reveals Dose-Dependent Selection of Atovaquone Resistance Mutations

J. Verhoef, S. Marzuki, A. Hoepelman, 2017, Antimicrobial Agents and Chemotherapy.

Deficiencies in Opsonic Defense to Pneumococci in the Human Newborn Despite Adequate Levels of Complement and Specific IgG Antibodies

J. Verhoef, A. Fleer, G. Rijkers, 1990, Pediatric Research.

The role of the phagocyte in resistance to infection

J. Verhoef, 1982, Antonie van Leeuwenhoek.

Quantitation of Conjugate Formation Between Human Polymorphonuclear Leukocytes and Antibody‐Coated Target Cells by Flow Cytometry: The Role of Fc Receptor and LFA‐1 Antigen

J. Verhoef, A. Fluit, J. Strijp, 1989, Journal of leukocyte biology.

Testing phagocytic cell function

J. Verhoef, F. Waldvogel, 1985, European Journal of Clinical Microbiology.

Degradation of Escherichia coli chromosomal and plasmid DNA in serum.

J. Verhoef, W. P. Hoekstra, J. V. van Strijp, 1984, Journal of general microbiology.

Stopping short the spread of methicillin-resistant Staphylococcus aureus.

J. Verhoef, 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Cross-resistance analyses and molecular typing of Staphylococcus aureus and Streptococcus spp. isolates resistant to quinupristin/dalfopristin.

J. Verhoef, F. Schmitz, A. Fluit, 1999, The Journal of antimicrobial chemotherapy.

Real time assay of Aspergillus should be used in SARS patients receiving corticosteroids

J. Verhoef, Y. P. Wu, R. Wei, 2003, British medical journal.

Nucleic acid sequence-based amplification (NASBA) detection of medically important Candida species.

J. Verhoef, B. van Gemen, A. Fluit, 1999, Journal of Microbiological Methods.

Inability of lipid A murine specific monoclonal antibody E5 to neutralize lipopolysaccharide biological activity in vitro

J. Verhoef, J. Cornelissen, H. Snippe, 1994 .

Recognition of Staphylococcus aureus by human phagocytes. Signals and disguises of the bacterial surface.

H. Verbrugh, J. Verhoef, P. Peterson, 1983, Scandinavian journal of infectious diseases. Supplementum.

Invasive group A streptococcal disease in the Netherlands: evidence for a protective role of anti-exotoxin A antibodies.

J. Schellekens, J. Musser, J. Verhoef, 2000, The Journal of infectious diseases.

Granulocyte colony‐stimulating factor enhances protection by anti‐K1 capsular IgM antibody in murine Escherichia coli sepsis

J. Verhoef, A. Hoepelman, K. V. van Kessel, 1997, European Journal of Clinical Investigation.

In Vitro Activity of Daptomycin against Gram-Positive European Clinical Isolates with Defined Resistance Determinants

J. Verhoef, A. Fluit, D. Milatovic, 2004, Antimicrobial Agents and Chemotherapy.

, Jan Verhoef and Dana with Defined Resistance Determinants Gram-Positive European Clinical Isolates In Vitro Activity of Daptomycin against

J. Verhoef, A. Fluit, D. Milatovic, 2004 .

Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells

J. Verhoef, A. Hoepelman, J. Scharringa, 2008, BMC Microbiology.

Binding of HIV-1 to human follicular dendritic cells.

M. Visser, J. Verhoef, T. Meerloo, 1993, Advances in Experimental Medicine and Biology.

Sensitivity to serum and phagocytosis by polymorphonuclear leucocytes ofE. coli

H. Verbrugh, J. Verhoef, R. Peters, 1978, Antonie van Leeuwenhoek.

Opsonic capacity of antisera raised against rough and smooth strains of Escherichia coli and Salmonella spp.

J. Verhoef, J. Marcelis, R. Vreede, 1985, Antonie van Leeuwenhoek.

Effect of lipopolysaccharide, lipid A and polysaccharide on phagocytic cell function

J. Verhoef, P. Henricks, 1983, Agents and Actions.

The role of sialic acid in phagocytic cell function

J. Verhoef, P. Henricks, Marijke E. Erne-van der Tol, 1982, Antonie van Leeuwenhoek.

Kinetics of IgG and completement dependent opsonization ofStaphylococcus aureus

H. Verbrugh, J. Verhoef, R. Peters, 1978, Antonie van Leeuwenhoek.

The effect of influenza virus on human polymorphonuclear leukocytes

H. Verbrugh, J. Verhoef, Y. Debets-Ossenkopp, 2004, Antonie van Leeuwenhoek.

The opsonisation and phagocytosis of group B by polymorphonuclear leucocytes. A comparison of sulphonamide sensitive and resistant strains

J. Verhoef, D. M. Jones, K. Ward, 1988 .

Electron Microscopic StudyofPhagocytosis ofEscherichia coliby HumanPolymorphonuclear Leukocytes

J. Verhoef, J. Strijp, J. Geuze, 1985 .

TheKeyRoleofPeptidoglycan intheOpsonization of Staphylococcus Aureus

J. Verhoef, 1977 .

Endocarditis caused by coagulase-negative staphylococci

J. Verhoef, P. Peterson, M. Laverdière, 2005, Infection.

LIPOPOLYSACCHARIDE INDUCES HYPERADHESION OF ENDOTHELIAL CELLS FOR NEUTROPHILS LEADING TO DAMAGE

J. Verhoef, P. Schneeberger, K. V. van Kessel, 1994, Shock.

Streptococcus pneumoniae: virulence factors, pathogenesis, and vaccines

J. Verhoef, A. Verheul, H. Snippe, 1995, Microbiological reviews.

Immune response in human pathology: infections caused by bacteria, viruses, fungi, and parasites

J. Verhoef, H. Snippe, 2005, Principles of Immunopharmacology.

Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent.

J. Verhoef, T. Meerloo, J. Goudsmit, 1993, Journal of immunology.